{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:08:05Z","timestamp":1791047285871,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd000284.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,1,6]],"date-time":"2014-01-06T00:00:00Z","timestamp":1388966400000}}],"reference-count":512,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd000284.pub3","type":"journal-article","created":{"date-parts":[[2014,1,6]],"date-time":"2014-01-06T15:37:15Z","timestamp":1389022635000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Chlorpromazine versus placebo for schizophrenia"],"prefix":"10.1002","volume":"2015","author":[{"given":"Clive E","family":"Adams","sequence":"first","affiliation":[{"name":"The University of Nottingham; Cochrane Schizophrenia Group; Institute of Mental Health Innovation Park, Triumph Road, Nottingham UK NG7 2TU"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George A","family":"Awad","sequence":"additional","affiliation":[{"name":"University of Toronto; Department of Psychiatry; Humber River Hospital 2175 Keele Street Toronto ON Canada M6M 3Z4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Rathbone","sequence":"additional","affiliation":[{"name":"Bond University; Faculty of Health Sciences and Medicine; Robina Gold Coast Queensland Australia 4229"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Thornley","sequence":"additional","affiliation":[{"name":"The Long Barn Blackthorn Road Marsh Gibbon Bucks UK OX27 0AG"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla","family":"Soares-Weiser","sequence":"additional","affiliation":[{"name":"Cochrane; Cochrane Editorial Unit; St Albans House, 57 - 59 Haymarket London UK SW1Y 4QX"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,1,6]]},"reference":[{"key":"10.1002\/14651858.CD000284.pub3-BIB0001|cit1","first-page":"20","article-title":"Chlorpromazine in the treatment of chronic schizophrenia","volume":"19","author":"Abrams","year":"1958","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0002|cit2","first-page":"852","article-title":"A controlled trial of ethylcrotonylurea","volume":"105","author":"Baker","year":"1959","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0003|cit3","first-page":"473","article-title":"Comprehensive clinical studies with thiothixene","volume":"36","author":"Ban","year":"1975","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1176\/ajp.120.2.180","article-title":"Behavioral toxicity associated with benzquinamide (Quantril) therapy in schizophrenic patients","volume":"120","author":"Bishop","year":"1963","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0005|cit5","first-page":"103","article-title":"Does sigma receptor antagonism predict clinical antipsychotic efficacy?","volume":"27","author":"Borison","year":"1991","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0014-2999(90)93880-Y","article-title":"Sigma receptor antagonism and antipsychotic actions in schizophrenic patients","volume":"183","author":"Borison","year":"1990","journal-title":"European Journal of Pharmacology"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1600-0447.1990.tb05301.x","article-title":"A placebo-controlled clinical trial of remoxipride and chlorpromazine in newly admitted schizophrenic patients with acute exacerbation","volume":"358","author":"Chouinard","year":"1990","journal-title":"Acta Psychiatria Scandinavica Supplementum"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF00592679","article-title":"Chlorpromazine in chronic schizophrenic women. I. Experimental design and effects at maximum point of treatment","volume":"2","author":"Clark","year":"1961","journal-title":"Psychopharmacologia"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/00006842-196305000-00002","article-title":"Chlorpromazine in chronic schizophrenic women: rate of onset and rate of dissipation of drug effects","volume":"25","author":"Clark","year":"1963","journal-title":"Psychosomatic Medicine"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/00005053-196404000-00005","article-title":"Chlorpromazine in chronic schizophrenic women: comparison of differential effects on various psychological modalities during and after treatment","volume":"138","author":"Ray","year":"1964","journal-title":"Journal of Nervous and Mental Diseases"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/cpt1970116883","article-title":"The effect of chlorpromazine on serum cholesterol in chronic schizophrenic patients","volume":"11","author":"Clark","year":"1970","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/00006842-196711000-00008","article-title":"Chlorpromazine in women with chronic schizophrenia: the effect on cholesterol levels and cholesterol-behavior relationships","volume":"29","author":"Clark","year":"1967","journal-title":"Psychosomatic Medicine"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF00403773","article-title":"Evaluation of trifluperidol in chronic schizophrenia","volume":"12","author":"Clark","year":"1968","journal-title":"Psychopharmacologia"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0014|cit14","first-page":"57","article-title":"Evaluation of butaperazine in chronic schizophrenia","volume":"97","author":"Clark","year":"1968","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/cpt1970116883","article-title":"The effect of chlorpromazine on serum cholesterol in chronic schizophrenic patients","volume":"11","author":"Clark","year":"1970","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/cpt1970115680","article-title":"Molindone in chronic schizophrenia","volume":"11","author":"Clark","year":"1970","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000468256","article-title":"The EEG effects of chemically and clinically dissimilar antipsychotics: molindone vs. chlorpromazine","volume":"6","author":"Serafetinides","year":"1971","journal-title":"International Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/cpt1970116883","article-title":"The effect of chlorpromazine on serum cholesterol in chronic schizophrenic patients","volume":"11","author":"Clark","year":"1970","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1001\/archpsyc.1972.01750280047009","article-title":"Chlorpromazine in chronic schizophrenia. The effect of age and hospitalization on behavioral dose-response relationships","volume":"27","author":"Clark","year":"1972","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/BF00412672","article-title":"Chlorpromazine in chronic schizophrenia - behavioral dose-response relationships","volume":"18","author":"Clark","year":"1970","journal-title":"Psychopharmacologia"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0021|cit21","first-page":"251","article-title":"EEG dose-response relationships of chlorpromazine in chronic schizophrenia: the effects on the various rhythms and on alpha blocking","volume":"4","author":"Serafetinides","year":"1972","journal-title":"Biological Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD000284.pub3-BIB0023|cit22","first-page":"37","article-title":"Phenothiazines in schizophrenics","volume":"6","author":"Clark","year":"1969","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0022|cit23","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1001\/archpsyc.1971.01750170020004","article-title":"Drug treatment in newly admitted schizophrenic patients","volume":"25","author":"Clark","year":"1971","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0024|cit24","first-page":"783","article-title":"Evaluation of loxapine succinate in chronic schizophrenia","volume":"33","author":"Clark","year":"1972","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000468249","article-title":"The EEG effects of dibenzoxazepines (loxapine succinate) as compared to CPZ: EEG changes as drug side effects","volume":"6","author":"Serafetinides","year":"1971","journal-title":"International Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/j.1552-4604.1977.tb05646.x","article-title":"Evaluation of butaclamol in chronic schizophrenic patients","volume":"17","author":"Clark","year":"1977","journal-title":"Journal of Clinical Pharmacology"},{"issue":"1","key":"10.1002\/14651858.CD000284.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/archpsyc.1968.01740070052008","article-title":"Family interaction patterns, drug treatment, and change in social aggression","volume":"19","author":"Cohen","year":"1968","journal-title":"Archives of General Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD000284.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/BF00429387","article-title":"Effects of various drugs on flicker fusion frequency. II. Phenothiazine derivatives (with reference to the dependence of the results on the chronological course of experiments","volume":"27","author":"Graupner","year":"1972","journal-title":"Psychopharmacologia"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1001\/archpsyc.1964.01720210028005","article-title":"Phenothiazine treatment in acute schizophrenia","volume":"10","author":"Cole","year":"1964","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1192\/bjp.111.471.120","article-title":"Changes in schizophrenic psychopathology and ward behaviour as a function of phenothiazine treatment","volume":"111","author":"Goldberg","year":"1965","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0031|cit31","first-page":"153","article-title":"Schizophrenic subtypes defined by response to drugs and placebo","volume":"29","author":"Goldberg","year":"1968","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0032|cit32","unstructured":"Cooper SJ Butler A Tweed J Welch CP Zotepine in the treatment of chronic schizophrenia 10th ECNP (European College of Neuropsychopharmacology) Congress. Vienna, Austria Vienna, Austria"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0033|cit33","doi-asserted-by":"crossref","unstructured":"Cooper SJ Raniwalla J Welch C Zotepine in acute exacerbation of schizophrenia: a comparison versus chlorpromazine and placebo XXth Collegium Internationale Neuro-psychopharmacologicum. Melbourne, Australia Melbourne, Australia 1996","DOI":"10.1016\/0924-977X(96)87990-9"},{"issue":"3","key":"10.1002\/14651858.CD000284.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1034\/j.1600-0447.2000.101003218.x","article-title":"A placebo controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia","volume":"101","author":"Cooper","year":"2000","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0035|cit35","unstructured":"Cooper SJ Tweed J Raniwalla J Welch C A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia Unpublished manuscript 1996"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0036|cit36","unstructured":"Cooper SJ Welch CP A comparison of zotepine and chlorpromazine on BPRS subscores 10th ECNP (European College of Neuropsychopharmacology) Congress. Vienna, Austria Vienna, Austria"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0037|cit37","first-page":"47","article-title":"Schizophrenia treated with and without chlorpromazine","volume":"55","author":"Dean","year":"1958","journal-title":"Rocky Mountain Medical Journal"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/archpsyc.1964.01720260056007","article-title":"Phenothiazines in prevention of psychiatric hospitalization","volume":"11","author":"Engelhardt","year":"1964","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/jama.1960.03020200019005","article-title":"Prevention of psychiatric hospitalization with use of psychopharmacological agents","volume":"173","author":"Engelhardt","year":"1960","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD000284.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1001\/archpsyc.1969.01740150059009","article-title":"Physician bias and the double-blind","volume":"20","author":"Engelhardt","year":"1969","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1001\/jama.1963.03710110033006","article-title":"Phenothiazines in prevention of psychiatric hospitalization. II. Duration of treatment exposure","volume":"186","author":"Engelhardt","year":"1963","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/archpsyc.1967.01730190100013","article-title":"Phenothiazines in prevention of psychiatric hospitalization. IV. Delay or prevention of hospitalization - a reevaluation","volume":"16","author":"Engelhardt","year":"1967","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0044|cit43","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00005053-196701000-00006","article-title":"On the modification of paranoid symptomatology","volume":"144","author":"Freedman","year":"1967","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0043|cit44","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/00005053-197001000-00008","article-title":"On the modification of paranoid symptomatology. II. Stylistic considerations and the effectiveness of phenothiazines","volume":"150","author":"Freedman","year":"1970","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/00005053-196806000-00007","article-title":"The hospitalization proneness scale as a predictor of response to phenothiazine treatment","volume":"6","author":"Rosen","year":"1968","journal-title":"Journal of Nervous and Mental Disease"},{"issue":"1","key":"10.1002\/14651858.CD000284.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00005053-196307000-00004","article-title":"The effects of imipramine and chlorpromazine on perceptual analytic ability, perceptual analytic responsivity and memory as revealed in rorschach responses","volume":"137","author":"Belmont","year":"1963","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0047|cit47","first-page":"370","article-title":"Comparative studies of chlorpromazine and imipramine. I. Drug discriminating patterns","volume":"3","author":"Fink","year":"1963","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0049|cit48","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1001\/archpsyc.1967.01730190120016","article-title":"Importance of psychiatric diagnosis in prediction of clinical drug effects","volume":"16","author":"Klein","year":"1967","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0050|cit49","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/BF00404952","article-title":"Psychiatric diagnosis and a typology of clinical drug effects","volume":"13","author":"Klein","year":"1968","journal-title":"Psychopharmacologia"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0048|cit50","first-page":"159","article-title":"Prediction of drug effect by diagnostic decision tree","volume":"29","author":"Klein","year":"1968","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1176\/ajp.122.10.1102","article-title":"Follow up study of formerly hospitalized voluntary psychiatric patients: the first two years","volume":"122","author":"Levenstein","year":"1966","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0052|cit52","first-page":"349","article-title":"A controlled comparative investigation of the effects of promazine, chlorpromazine, and a placebo in chronic psychosis","volume":"105","author":"Fleming","year":"1959","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1001\/archneurpsyc.1958.02340060095013","article-title":"Chlorpromazine used with an intensive occupational therapy program. A.M.A","volume":"79","author":"Grygier","year":"1958","journal-title":"Archives of Neurology and Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00005053-196205000-00008","article-title":"Efficacy of trifluoperazine on withdrawal in chronic schizophrenia","volume":"134","author":"Gwynne","year":"1962","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00005053-195510000-00001","article-title":"A study of chlorpromazine: methodology and results with chronic semi-disturbed schizophrenics","volume":"122","author":"Hall","year":"1955","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1176\/ajp.123.2.211","article-title":"Phenothiazine derivatives and morphologic changes in the liver","volume":"123","author":"Hollister","year":"1966","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1176\/ajp.132.10.1023","article-title":"The immediate effects of chlorpromazine in newly admitted schizophrenic patients","volume":"132","author":"Hamill","year":"1975","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0058|cit58","first-page":"40","article-title":"A controlled trial of Thiopropazate Dihydrochloride (Dartalan), Chlorpromazine and occupational therapy in chronic schizophrenics","volume":"106","author":"Hamilton","year":"1960","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1177\/009127006200200305","article-title":"A reference study of ataraxics. A two-week double blind outpatient evaluation","volume":"2","author":"Hankoff","year":"1962","journal-title":"Journal of New Drugs"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005053-195809000-00002","article-title":"Chlorpromazine in schizophrenic withdrawal and in the withdrawn schizophrenic","volume":"127","author":"Hine","year":"1958","journal-title":"Journal of Nervous and Mental Diseases"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1001\/archpsyc.1977.01770140061008","article-title":"Prediction of relapse in schizophrenic outpatients treated by drug and sociotherapy","volume":"34","author":"Goldberg","year":"1977","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0064|cit62","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1001\/archpsyc.1973.01750310038007","article-title":"Drug and sociotherapy in the aftercare of schizophrenic patients. One-year relapse rates","volume":"28","author":"Hogarty","year":"1973","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/archpsyc.1974.01760170011002","article-title":"Drug and sociotherapy in the aftercare of schizophrenic patients. III. Adjustment of non relapsed patients","volume":"31","author":"Hogarty","year":"1974","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0062|cit64","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/archpsyc.1974.01760170005001","article-title":"Drug and sociotherapy in the aftercare of schizophrenic patients. II. Two-year relapse rates","volume":"31","author":"Hogarty","year":"1974","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1001\/archpsyc.1977.01770150055005","article-title":"Temporal effects of drug and placebo in delaying relapse in schizophrenic outpatients","volume":"34","author":"Hogarty","year":"1977","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00004714-198402000-00003","article-title":"Pharmacogenic depression among outpatient schizophrenic patients - a failure to substantiate","volume":"4","author":"Hogarty","year":"1984","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1001\/archpsyc.1973.04200040034006","article-title":"Premorbid asocial adjustment and response to phenothiazine treatment among schizophrenic inpatients","volume":"29","author":"Klein","year":"1973","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005053-196107000-00001","article-title":"The comparative effectiveness of six phenothiazine compounds, phenobarbital and inert placebo in the treatment of acutely ill patients: global measures of severity of illness","volume":"133","author":"Kurland","year":"1961","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00005053-196101000-00010","article-title":"Comparative studies of the phenothiazine tranquilizers: methodological and logistical considerations","volume":"132","author":"Kurland","year":"1961","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1176\/ajp.115.11.1028","article-title":"Pre-admission drug treatment of state psychiatric hospital patients","volume":"115","author":"Kurland","year":"1959","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0033-3182(60)72984-0","article-title":"The phenothiazine tranquilizers - their neurological complications and significance","volume":"1","author":"Kurland","year":"1960","journal-title":"Psychosomatics"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1192\/bjp.113.502.950","article-title":"Chlorpromazine and the untreated chronic schizophrenic: a long-term trial","volume":"113","author":"Letemendia","year":"1967","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/BF00432759","article-title":"Prophylactic effect of neuroleptics in symptom-free schizophrenics","volume":"77","author":"Nishikawa","year":"1982","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0074|cit74","first-page":"196","article-title":"A comparison of trifluopromazine, chlorpromazine and a placebo in twenty-one chronic schizophrenic patients","author":"Payne","year":"1960","journal-title":"Manitoba Medical Review"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1192\/bjp.139.2.105","article-title":"Propranolol in schizophrenia. I. Comparison of propranolol, chlorpromazine and placebo","volume":"139","author":"Peet","year":"1981","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0076|cit76","first-page":"209","article-title":"Tardive dyskinesia in schizophrenic patients treated with psychotropic drugs","volume":"2","author":"Crane","year":"1968","journal-title":"Agressologie"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0077|cit77","first-page":"19","article-title":"Incidence and significance of chlorpromazine-induced eye changes","volume":"29","author":"Long","year":"1968","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0078|cit78","first-page":"983","article-title":"A 12-year follow-up study of chronic schizophrenics","volume":"33","author":"Gardos","year":"1982","journal-title":"Hospital and Community Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0079|cit79","first-page":"32","article-title":"Agranulocyctosis and phenothiazines","volume":"29","author":"Mandel","year":"1968","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/archpsyc.1968.01740040098013","article-title":"High dose chlorpromazine therapy in chronic schizophrenia. Report of National Institute of Mental Health - psychopharmacology research branch collaborative study group","volume":"18","author":"Prien","year":"1968","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/archpsyc.1970.01750050080011","article-title":"Ocular changes occurring with prolonged high dose chlorpromazine therapy. Results from a collaborative study","volume":"23","author":"Prien","year":"1970","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1192\/bjp.115.523.679","article-title":"Relapse in chronic schizophrenics following abrupt withdrawal of tranquillizing medication","volume":"115","author":"Prien","year":"1968","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0083|cit83","first-page":"739","article-title":"Indications for high dose chlorpromazine therapy in chronic schizophrenia","volume":"31","author":"Prien","year":"1970","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0084|cit84","first-page":"59","article-title":"A double blind controlled study on the role of brahmyadiyoga and tagara in navonmada (acute schizophrenia)","volume-title":"Ayurvedic Management of Unmada (Schizophrenia)","author":"Ramu","year":"1999"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0085|cit85","first-page":"77","article-title":"A DOUBLE BLIND controlled study on the role of brahmyadiyoga and tagara in jirnomada (chronic schizophrenia)","volume-title":"Ayurvedic Management of Unmada (Schizophrenia)","author":"Ramu","year":"1999"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000468327","article-title":"Are there schizophrenics for whom drugs may be unnecessary or contraindicated?","volume":"13","author":"Rappaport","year":"1978","journal-title":"International Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0087|cit87","first-page":"265","article-title":"Acute paranoid schizophrenia (treatment with chlorpromazine, trifluoperazine and placebo)","volume":"27","author":"Reardon","year":"1966","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0088|cit88","first-page":"112","article-title":"Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia","volume":"35","author":"Reschke","year":"1974","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1037\/h0023595","article-title":"Effects of chlorpromazine on primary-process thought manifestations","volume":"71","author":"Saretsky","year":"1966","journal-title":"Journal of Abnormal Psychology"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0090|cit90","first-page":"151","article-title":"A comparison of thioridazine, chlorpromazine, and placebo: a double-blind controlled study on the treatment of chronic, hospitalized, schizophrenic patients","volume":"22","author":"Schiele","year":"1961","journal-title":"Journal of Clinical and Experiemental Psychopathology"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0091|cit91","first-page":"263","article-title":"Psychological effects of single dose antipsychotic medication","volume":"7","author":"Serafetinides","year":"1973","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00005053-197201000-00005","article-title":"Haloperidol, clopenthixol, and chlorpromazine in chronic schizophrenia. Chemically unrelated antipsychotics as therapeutic alternatives","volume":"154","author":"Serafetinides","year":"1972","journal-title":"Journal of Nervous and Mental Diseases"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0094|cit93","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000468000","article-title":"A method of quantifying EEG for psychopharmacological research","volume":"8","author":"Serafetinides","year":"1973","journal-title":"International Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0093|cit94","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00005053-197211000-00010","article-title":"Haloperidol, clopenthixol, and chlorpromazine in chronic schizophrenia. II. The electroencephalographic effects of chemically unrelated antipsychotics","volume":"155","author":"Serafetinides","year":"1972","journal-title":"Journal of Nervous and Mental Diseases"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1136\/jnnp.19.3.232","article-title":"A controlled clinical study of chlorpromazine and reserpine","volume":"19","author":"Shepherd","year":"1956","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1001\/archpsyc.1965.01720350078010","article-title":"Long-term follow-up study of schizophrenic patients","volume":"12","author":"Simon","year":"1965","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1176\/ajp.114.12.1077","article-title":"A controlled study of the short-term differential treatment of schizophrenia","volume":"114","author":"Simon","year":"1958","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0098|cit98","first-page":"153","article-title":"A clinical study of chlorpromazine and chlordiazepoxide","volume":"25","author":"Smith","year":"1961","journal-title":"Connecticut State Medical Journal"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0099|cit99","first-page":"1417","article-title":"Phenothiazine side-effects. Comparison of two major tranquillizers","volume":"106","author":"Somerville","year":"1960","journal-title":"British Journal of Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD000284.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/archpsyc.1977.01770180019001","article-title":"Phenothiazine effects on psychological and psychophysiological dysfunction in chronic schizophrenics","volume":"34","author":"Spohn","year":"1977","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0102|cit101","first-page":"221","article-title":"Comparative study of two drugs and a placebo in chronic schizophrenia","volume":"22","author":"Tetreault","year":"1969","journal-title":"Actualites Pharmacologiques"},{"issue":"2","key":"10.1002\/14651858.CD000284.pub3-BIB0101|cit102","first-page":"74","article-title":"Comparative study of TPS-23, chlorpromazine and placebo in chronic schizophrenic patients","volume":"30","author":"Tetreault","year":"1969","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0140-6736(55)90587-0","article-title":"Chlorpromazine in psychiatry","volume":"1","author":"Vaughan","year":"1955","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0104|cit104","first-page":"199","article-title":"The relative efficacy of \"Vespral\" and chlorpromazine in the treatment of a group of chronic schizophrenic patients","volume":"105","author":"Walsh","year":"1959","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0105|cit105","first-page":"527","article-title":"Clinical trial of RO 5-0690 and chlorpromazine on disturbed chronic schizophrenic patients","volume":"21","author":"Weckowicz","year":"1960","journal-title":"Diseases of the Nervous System"},{"issue":"4","key":"10.1002\/14651858.CD000284.pub3-BIB0106|cit106","first-page":"160","article-title":"A double-blind comparative study of pheytoin and chlorpromazine in chronic schizophrenics","volume":"6","author":"Xiong","year":"1994","journal-title":"Medical Journal of Chinese Civil Administration"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1176\/ajp.116.11.973","article-title":"Evaluation of tranquilizing drugs in the management of acute mental disturbance","volume":"117","author":"Abse","year":"1960","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/BF00403638","article-title":"An exploration of the autonomic effects of phenothiazines","volume":"7","author":"Acker","year":"1965","journal-title":"Psychopharmacologia"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0109|cit109","first-page":"331","article-title":"The action of a medication and the physician's expectations","volume":"51","author":"Affleck","year":"1966","journal-title":"Nebraska State Medical Journal"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0110|cit110","first-page":"233","article-title":"Role of ECT phenothiazine combination in schizophrenia","volume":"27","author":"Agarwal","year":"1985","journal-title":"Indian Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD000284.pub3-BIB0111|cit111","first-page":"1","article-title":"Current status of pharmacotherapy in schizophrenia","volume":"20","author":"Akimoto","year":"1966","journal-title":"Folia Psychiatrica et Neurologica Japonica"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1176\/ajp.122.11.1258","article-title":"Evaluation of treatment with recorded interviews","volume":"122","author":"Alpert","year":"1966","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1176\/ajp.135.11.1329","article-title":"Paradoxical reaction to L-dopa in schizophrenic patients","volume":"135","author":"Alpert","year":"1978","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD000284.pub3-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/1097-4679(196410)20:4<462::AID-JCLP2270200415>3.0.CO;2-V","article-title":"The use of adjective check lists with psychotic patients: the problem of pseudo-responses","volume":"20","author":"Alson","year":"1964","journal-title":"Journal of Clinical Psychology"},{"issue":"2","key":"10.1002\/14651858.CD000284.pub3-BIB0115|cit115","first-page":"187","article-title":"Dyskinetic symptoms in profoundly retarded residents following neuroleptic withdrawal and during methylphenidate treatment","volume":"29","author":"Aman","year":"1985","journal-title":"Journal of Mental Deficiency Research"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0116|cit116","first-page":"20","article-title":"A standard-controlled clinical study with benzquinamide in the treatment of chronic schizophrenic patients","volume":"13","author":"Amin","year":"1977","journal-title":"Psychopharmacology Bulletin"},{"issue":"4","key":"10.1002\/14651858.CD000284.pub3-BIB0117|cit117","first-page":"406","article-title":"Nicotinic acid in the treatment of newly admitted schizophrenic patients: a placebo-controlled study","volume":"5","author":"Ananth","year":"1972","journal-title":"Internationale Zeitschrift Fur Klinische Pharmakologie Therapie und Toxikologie"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1192\/bjp.128.5.451","article-title":"A controlled trial of phenothiazine withdrawal in chronic schizophrenic patients","volume":"128","author":"Andrews","year":"1976","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0119|cit119","first-page":"287","article-title":"A comparison of tetrabenazine and chlorpromazine in chronic schizophrenia","volume":"107","author":"Ashcroft","year":"1961","journal-title":"Journal of Mental Science (British Journal of Psychiatry from 1963)"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00004714-198404020-00005","article-title":"Subjective response to antipsychotic drugs: failure to replicate predictions of outcome","volume":"4","author":"Ayers","year":"1984","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0121|cit121","first-page":"116","article-title":"Effects of Largactil in mental syndomes","volume":"71","author":"Azima","year":"1954","journal-title":"Canadian Medical Association Journal"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0122|cit122","first-page":"324","article-title":"Evaluation of cognitive effects of ECT: preliminary observations","volume":"23","author":"Bagadia","year":"1981","journal-title":"Indian Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0123|cit123","first-page":"119","article-title":"Negative findings with megavitamins in schizophrenic patients - preliminary report","volume":"1","author":"Ban","year":"1977","journal-title":"Communications in Psychopharmacology"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1177\/070674377502000621","article-title":"Megavitamin treatment of schizophrenia","volume":"20","author":"Hoffer","year":"1975","journal-title":"Canadian Psychiatric Association Journal"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/0191-8869(90)90026-N","article-title":"The effect of a small dose of chlorpromazine on a measure of 'cognitive inhibition'","volume":"11","author":"Beech","year":"1990","journal-title":"Personality and Individual Differences"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1192\/bjp.106.442.317","article-title":"The effect of chlorpromazine on the incidence of epileptic phenomena during insulin coma therapy: A statistical investigation","volume":"106","author":"Benaim","year":"1960","journal-title":"Journal of Mental Science"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1176\/ajp.112.10.782","article-title":"Clinical investigation of chlorpromazine and reserpine in private psychiatric practice","volume":"112","author":"Bennett","year":"1956","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD000284.pub3-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0022-3956(64)90029-9","article-title":"Effects of chlorpromazine and imipramine on systolic blood pressure in psychiatric patients: Relationships to age, diagnosis and initial blood pressure","volume":"2","author":"Blumberg","year":"1964","journal-title":"Journal of Psychiatric Research"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/cpt1969103350","article-title":"Chlorpromazine-procyclidine and imipramine: effects on thyroid function in psychiatric patients","volume":"10","author":"Blumberg","year":"1969","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2125.1975.tb00468.x","article-title":"Increased platelet aggregation responses to 5-hydroxytryptamine in patients taking chlorpromazine","volume":"2","author":"Boullin","year":"1975","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1176\/ajp.113.6.530","article-title":"The ataractic drugs: the present position of chlorpromazine, frenquel, pacatal, and reserpine in the psychiatric hospital","volume":"113","author":"Bowes","year":"1956","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0033-3182(71)71519-9","article-title":"A comparison between chlorpromazine and thiothixene in a Veterans Administration Hospital population","volume":"12","author":"Bressler","year":"1971","journal-title":"Psychosomatics"},{"issue":"9","key":"10.1002\/14651858.CD000284.pub3-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1176\/ajp.142.9.1106","article-title":"Effect of methadone plus neuroleptics on treatment-resistant chronic paranoid schizophrenia","volume":"142","author":"Brizer","year":"1985","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0134|cit134","first-page":"625","article-title":"The assessment of thiothixene in chronic schizophrenia. A double-blind controlled trial","volume":"36","author":"Burnett","year":"1975","journal-title":"Diseases of the Nervous System"},{"issue":"1","key":"10.1002\/14651858.CD000284.pub3-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF01878151","article-title":"Treatment of schizophrenic disorder, paranoid type, with intramuscular recombinant alpha-2b interferon","volume":"7","author":"Cabrera Gomez","year":"1994","journal-title":"Biotherapy"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1176\/ajp.120.6.578","article-title":"Phenothiazine excretion in chronic schizophrenics","volume":"120","author":"Caffey","year":"1963","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD000284.pub3-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0021-9681(64)90075-X","article-title":"Discontinuation or reduction of chemotherapy in chronic schizophrenics","volume":"17","author":"Caffey","year":"1964","journal-title":"Journal of Chronic Diseases"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0138|cit138","first-page":"1399","article-title":"Practical considerations on treatment with antipsychotic preparations","volume":"75","author":"Caffey","year":"1975","journal-title":"Zhurnal Nevropatologii i Psikhiatrii"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0139|cit139","first-page":"759","article-title":"Acute responses of schizophrenic children to a sedative and a 'stimulating' neuroleptic: a pharmacologic yardstick","volume":"14","author":"Campbell","year":"1972","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/archpsyc.1970.01750010072013","article-title":"Thiothixene in young disturbed children. A pilot study","volume":"23","author":"Campbell","year":"1970","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1001\/archpsyc.1969.01740170080012","article-title":"Chlorpromazine and body image. Effects on chronic schizophrenics","volume":"20","author":"Cardone","year":"1969","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0142|cit142","unstructured":"Carrillo C Pharmacologlal treatment of the emotionally unstable character disorder Vth World Congress of Psychiatry. Ciudad de Mexico 1971"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1001\/archpsyc.1960.03590080086012","article-title":"Drug therapy in schizophrenia. A controlled study of the relative effectiveness of chlorpromazine, promazine, phenobarbital, and placebo","volume":"2","author":"Casey","year":"1960","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1176\/ajp.117.11.997","article-title":"Combined drug therapy of chronic schizophrenics. Controlled evaluation of placebo, dextro-amphetamine, imipramine, isocarboxazid and trifluoperazine added to maintenance doses of chlorpromazine","volume":"117","author":"Casey","year":"1961","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1600-0447.1973.tb04399.x","article-title":"Clinical and work performance variables in phenothiazine therapy of schizophrenia","volume":"49","author":"Chacon","year":"1973","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"6","key":"10.1002\/14651858.CD000284.pub3-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0010-440X(72)90055-7","article-title":"Work study in the assessment of the effects of phenothiazines in schizophrenia","volume":"13","author":"Chacon","year":"1972","journal-title":"Comprehensive Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1176\/ajp.118.6.552","article-title":"A comparison of the effectiveness of triluoperazine and chlorpromazine in schizophrenia","volume":"118","author":"Childers","year":"1961","journal-title":"American Journal of Psychiatry"},{"issue":"2-3","key":"10.1002\/14651858.CD000284.pub3-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/j.1552-4604.1977.tb04602.x","article-title":"Penfluridol in the maintenance treatment of schizophrenic patients newly discharged from a brief therapy unit","volume":"17","author":"Chouinard","year":"1977","journal-title":"Journal of Clinical Pharmacology"},{"issue":"1","key":"10.1002\/14651858.CD000284.pub3-BIB0149|cit149","first-page":"136","article-title":"Fluspirilene in the treatment of newly admitted schizophrenic patients","volume":"19","author":"Chouinard-G","year":"1983","journal-title":"Psychopharmacology Bulletin."},{"key":"10.1002\/14651858.CD000284.pub3-BIB0150|cit150","first-page":"138","article-title":"The current status of clozapine","volume":"19","author":"Claghorn","year":"1983","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1001\/jama.1970.03180130071025","article-title":"Ocular pigment deposits: drug-induced false-positives","volume":"214","author":"Clark","year":"1970","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/cpt1970116883","article-title":"The effect of chlorpromazine on serum cholesterol in chronic schizophrenic patients","volume":"11","author":"Clark","year":"1970","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0154|cit153","first-page":"191","article-title":"A preliminary report on clinical response and blood levels of chlorpromazine and its sulfoxide during chlorpromazine therapy in chronic schizophrenic patients","volume-title":"Pharmacokinetics of Psychoactive Drugs","author":"Clark","year":"1976"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0155|cit154","first-page":"28","article-title":"A preliminary report on clinical response and blood levels of chlorpromazine and its sulfoxide during chlorpromazine therapy in chronic schizophrenic patients","volume":"11","author":"Clark","year":"1975","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0153|cit155","first-page":"43","article-title":"Chlorpromazine kinetics and clinical response","volume":"14","author":"Clark","year":"1978","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0156|cit156","first-page":"177","article-title":"Changes in the electroencephalogram, the electrodermogram, and the electromyogram provoked by chlorpromazine in man","volume":"20","author":"Cobb","year":"1956","journal-title":"Abstracts of World Medicine"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0157|cit157","first-page":"369","article-title":"Differences in clinical effects of three phenothiazines in \"acute\" schizophrenia","volume":"28","author":"Cole","year":"1967","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/070674376200700403","article-title":"Chlorpromazine, trifluoperazine and placebo with long term mental hospital patients","volume":"7","author":"Coons","year":"1962","journal-title":"Canadian Psychiatric Association Journal"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1176\/ajp.112.11.898","article-title":"Chlorpromazine: alone and as an adjunct to group psychotherapy in the treatment of psychiatric patients","volume":"4","author":"Cowden","year":"1956","journal-title":"American Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD000284.pub3-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1001\/archneur.1970.00480200082009","article-title":"High doses of trifluperazine and tardive dyskinesia","volume":"22","author":"Crane","year":"1970","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1176\/ajp.127.10.1407","article-title":"Persistence of neurological symptoms due to neuroleptic drugs","volume":"127","author":"Crane","year":"1971","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1192\/bjp.148.2.120","article-title":"The Northwick Park study of first episodes of schizophrenia. II. A randomised controlled trial of prophylactic neuroleptic treatment","volume":"148","author":"Crow","year":"1986","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1192\/bjp.148.2.115","article-title":"The Northwick Park study of first episodes of schizophrenia. I. Presentation of the illness and problems relating to admission","volume":"148","author":"Johnstone","year":"1986","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1192\/bjp.148.2.128","article-title":"The Northwick Park study of first episodes of schizophrenia. III. Short-term outcome in trial entrants and trial eligible patients","volume":"148","author":"MacMillan","year":"1986","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0140-6736(72)91943-5","article-title":"Double-blind trial of fluphenazine decanoate","volume":"2","author":"Curry","year":"1972","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1001\/archneurpsyc.1957.02330370075012","article-title":"Effects of \"tranquilizers\" upon pathological activity in psychotic patients: II. Reserpine","volume":"78","author":"Cutler","year":"1957","journal-title":"Archives of Neurology and Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1136\/bmj.2.5517.793","article-title":"Treatment and outcome of anorexia nervosa","volume":"2","author":"Dally","year":"1966","journal-title":"British Medical Journal"},{"issue":"3","key":"10.1002\/14651858.CD000284.pub3-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/BF02245122","article-title":"Effects of chlorpromazine and lorazepam on explicit memory, repetition priming and cognitive skill learning in healthy volunteers","volume":"108","author":"Danion","year":"1992","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD000284.pub3-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1037\/h0041643","article-title":"Stylus maze performance of chronic schizophrenics taking chlorpromazine","volume":"22","author":"Daston","year":"1958","journal-title":"Journal of Consulting Psychology"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/1097-4679(195901)15:1<106::AID-JCLP2270150128>3.0.CO;2-E","article-title":"Effects of two phenothiazine drugs on concentrative attention span of chronic schizophrenics","volume":"15","author":"Daston","year":"1959","journal-title":"Journal of Clinical Psychology"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0171|cit171","first-page":"1694","article-title":"The use of chlorpromazine in schizophrenia","volume":"69","author":"Davies","year":"1973","journal-title":"Nursing Times"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0172|cit172","first-page":"925","article-title":"Mefenamic acid and chlorpromazine in porphyria variegata","volume":"41","author":"Dean","year":"1967","journal-title":"South African Medical Journal"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00005053-195511000-00008","article-title":"Studies on Mescaline. VI. Therapeutic Aspects of the Mescaline-Chlorpromazine Combination","volume":"122","author":"Denber","year":"1955","journal-title":"Journal of Nervous and Mental Diseases"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1176\/ajp.112.12.1021","article-title":"Chlorpromazine in the treatment of mental illness. III. The problem of depression","volume":"112","author":"Denber","year":"1956","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0175|cit175","first-page":"76","article-title":"Chlorpromazine-diethazine in the treatment of depression","volume":"18","author":"Denber","year":"1957","journal-title":"Diseases of the Nervous System"},{"issue":"3","key":"10.1002\/14651858.CD000284.pub3-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/(SICI)1099-1077(200004)15:3<179::AID-HUP156>3.0.CO;2-N","article-title":"Ritanserin as add on medication to neuroleptic therapy for patients with chronic or subchronic schizophrenia","volume":"15","author":"Boer","year":"2000","journal-title":"Human Psychopharmacology"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF02431534","article-title":"Possible interactions between zolpidem, a new sleep inducer and chlorpromazine, a phenothiazine neuroleptic","volume":"96","author":"Desager","year":"1988","journal-title":"Psychopharmacology Berlin"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0178|cit178","first-page":"176","article-title":"A comparison of mesoridazine and chlorpromazine in chronic psychiatric patients","volume":"9","author":"Douglas","year":"1969","journal-title":"Journal of Clinical Pharmacology and The Journal of New Drugs"},{"issue":"2","key":"10.1002\/14651858.CD000284.pub3-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2466\/pms.1963.17.2.511","article-title":"Effect of phenothiazines on the thinking of acute schizophrenics","volume":"17","author":"Downing","year":"1963","journal-title":"Perceptual and Motor Skills"},{"issue":"2","key":"10.1002\/14651858.CD000284.pub3-BIB0180|cit180","first-page":"193","article-title":"Efficacy of lithium in schizophrenia","volume":"23","author":"Dube","year":"1981","journal-title":"Indian Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1600-0447.1992.tb01446.x","article-title":"Effects of antipsychotic drugs on memory functions of schizophrenic patients","volume":"85","author":"Eitan","year":"1992","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"487","key":"10.1002\/14651858.CD000284.pub3-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1192\/bjp.112.487.633","article-title":"A controlled trial of anti-parkinson drugs in drug-induced parkinsonism","volume":"112","author":"Ekdawi","year":"1966","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0183|cit183","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1136\/bmj.2.4887.560","article-title":"Effect of chlorpromazine on the behaviour of chronically overactive psychotic patients","volume":"2","author":"Elkes","year":"1954","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0184|cit184","first-page":"25","article-title":"A controlled, blind study of effects of thorazine on psychotic behavior","volume":"20","author":"Feldman","year":"1956","journal-title":"Bulletin of the Menninger Clinic"},{"issue":"15","key":"10.1002\/14651858.CD000284.pub3-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1001\/jama.1958.02990150042009","article-title":"Comparative study of chlorpromazine and insulin coma in therapy of psychosis","volume":"166","author":"Fink","year":"1958","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0186|cit186","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF00404162","article-title":"Clinical efficacy of chlorpromazine-procyclidine combination, imipramine and placebo in depressive disorders","volume":"7","author":"Fink","year":"1965","journal-title":"Psychopharmacologia"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0187|cit187","unstructured":"Fleischhacker W Broadening treatment perspectives of schizophrenia: a clinical update on seroquel 8th Congress of the European College of Neuropsychopharmacology; 1995 Sep 30 - Oct 4; Venice, Italy 1995"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0188|cit188","first-page":"749","article-title":"Investigation of a new compound, B.W.203, and of Chlorpromazine in the treatment of psychosis","volume":"104","author":"Fleming","year":"1958","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0189|cit189","first-page":"201","article-title":"Combined Chlorpromazine and Reserpine in the treatment of chronic psychotics","volume":"104","author":"Foote","year":"1958","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0190|cit190","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0022-3956(67)90016-7","article-title":"The role of personality variables in response to chlorpromazine, dextroamphetamine and placebo","volume":"5","author":"Forrest","year":"1967","journal-title":"Journal of Psychiatric Research"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0191|cit191","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1176\/ajp.113.1.22","article-title":"Treatment of hyperkinetic emotionally disturbed children with prolonged administration of chlorpromazine","volume":"113","author":"Freed","year":"1956","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD000284.pub3-BIB0192|cit192","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1037\/h0021923","article-title":"Communication of body complaints and paranoid symptom change under conditions of phenothiazine treatment","volume":"1","author":"Freedman","year":"1965","journal-title":"Journal of Personality and Social Psychology"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0193|cit193","first-page":"213","article-title":"Effects of chlorpromazine and reserpine in chronic schizophrenic patients","volume":"17","author":"Freeman","year":"1956","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0194|cit194","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1001\/archneurpsyc.1956.02330290044005","article-title":"Effects of chlorpromazine on chronic lobotomized schizophrenic patients. A.M.A","volume":"76","author":"Freeman","year":"1956","journal-title":"Archives of Neurology and Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD000284.pub3-BIB0195|cit195","first-page":"289","article-title":"A double blind comparison of mesoridazine and chlorpromazine in chronic schizophrenics","volume":"34","author":"Freeman","year":"1973","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0196|cit196","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/00005053-196008000-00003","article-title":"The effect of chlorpromazine on the variability of motor task performance in schizophrenics","volume":"131","author":"Friedhoff","year":"1960","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0197|cit197","first-page":"16","article-title":"Controlled study on the value of chlorpromazine in allaying anxiety","volume":"17","author":"Fromm","year":"1956","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0198|cit198","first-page":"1984","article-title":"Evaluation of Chlorpromazine in Comparison with other Methods of treatments of hospitalized psychiatric patients, using the lorr multidimensional scale for rating psychiatric patients","volume":"1","author":"Gaitz","year":"1955","journal-title":"Psychiatric Research Reports"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0199|cit199","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00005053-196808000-00009","article-title":"Predicting response to phenothiazines: the right drug for the right patient","volume":"147","author":"Galbrecht","year":"1968","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0200|cit200","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1177\/070674378803300906","article-title":"Relationship of adverse drug reactions to length of hospital-stay in genetically subgrouped schizophrenics","volume":"33","author":"Galdi","year":"1988","journal-title":"Canadian Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0201|cit201","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1176\/ajp.119.9.882","article-title":"The relationship between serotonin antagonism and tranquilizing activity","volume":"119","author":"Gallant","year":"1963","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0202|cit202","first-page":"447","article-title":"BL-KR140: a controlled evaluation in chronic schizophrenic patients previously stabilized on chlorpromazine","volume":"9","author":"Gallant","year":"1967","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0203|cit203","first-page":"77","article-title":"Objective measurement of psychiatric changes produced by chlorpromazine and reserpine in chronic schizophrenia","volume":"1","author":"Gardner","year":"1955","journal-title":"Psychiatric Research Reports"},{"issue":"12","key":"10.1002\/14651858.CD000284.pub3-BIB0204|cit204","first-page":"609","article-title":"Trifluoperazine and chlorpromazine in combination and individually","volume":"10","author":"Gardos","year":"1968","journal-title":"Current Therapeutic Research Clinical and Experimental"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0205|cit205","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1176\/ajp.133.1.32","article-title":"Maintenance antipsychotic therapy: is the cure worse than the disease?","volume":"133","author":"Gardos","year":"1976","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0206|cit206","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/00005053-196208000-00008","article-title":"Effects of chlorpromazine on behaviour in emotionally disturbed children","volume":"135","author":"Garfield","year":"1962","journal-title":"Journal of Nervous and Mental Diseases"},{"issue":"2","key":"10.1002\/14651858.CD000284.pub3-BIB0207|cit207","first-page":"491","article-title":"Effects of censure and chlorpromazine on visual discrimination behavior of schizophrenic and alcoholic patients","volume":"4","author":"Garmezy","year":"1969","journal-title":"Proceedings of the Annual Convention of the American Psychological Association"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0208|cit208","first-page":"936","article-title":"Comparative study of trifluperidol and trifluoperazine in the treatment of acute schizophrenia","volume":"96","author":"Gauthier","year":"1967","journal-title":"Union Medicale du Canada"},{"issue":"6","key":"10.1002\/14651858.CD000284.pub3-BIB0209|cit209","first-page":"333","article-title":"A double blind comparison of AL 1021 and chlorpromazine in hospitalized schizophrenics","volume":"15","author":"Gendron","year":"1973","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0210|cit210","first-page":"269","article-title":"A controlled clinical psychiatric study of chlorpromazine","volume":"18","author":"Gibbs","year":"1957","journal-title":"Journal of Clinical and Experimental Psychopathology"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0211|cit211","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1176\/ajp.113.3.254","article-title":"A controlled clinical psychiatric study of the drug chlorpromazine","volume":"113","author":"Gibbs","year":"1956","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0212|cit212","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2466\/pr0.1957.3.3.561","article-title":"Effects of Thorazine on Wechsler scores of adult catatonic schizophrenics","volume":"3","author":"Gilgash","year":"1957","journal-title":"Psychological Reports"},{"issue":"5","key":"10.1002\/14651858.CD000284.pub3-BIB0213|cit213","first-page":"S153","article-title":"Schizophrenic subtypes defined by response to drugs and placebo","volume":"29","author":"Goldberg","year":"1968","journal-title":"Diseases of the Nervous System"},{"issue":"2","key":"10.1002\/14651858.CD000284.pub3-BIB0214|cit214","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1600-0447.1970.tb02108.x","article-title":"A comparison of oxypertine and chlorpromazine in chronic schizophrenia","volume":"46","author":"Goldberg","year":"1970","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0215|cit215","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1001\/archpsyc.1972.01750220077015","article-title":"Prediction of response to phenothiazines in schizophrenia. A crossvalidation study","volume":"26","author":"Goldberg","year":"1972","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0216|cit216","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1001\/jama.1955.02950320004002","article-title":"Treatment of psychotic states with chlorpromazine","volume":"157","author":"Goldman","year":"1955","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0217|cit217","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1176\/ajp.115.5.443","article-title":"Termination of chlorpromazine with schizophrenic patients","volume":"115","author":"Good","year":"1958","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0218|cit218","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00005053-195808000-00009","article-title":"Influence of chlorpromazine on certain biochemical variables of chronic male schizophrenics","volume":"127","author":"Mefferd","year":"1958","journal-title":"Journal of Nervous and Mental Diseases"},{"issue":"778","key":"10.1002\/14651858.CD000284.pub3-BIB0219|cit219","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/bmj.4.5778.25","article-title":"Persistent phenothiazine dyskinesia treated with tetrabenazine","volume":"4","author":"Godwin-Austen","year":"1971","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0220|cit220","unstructured":"Goyne J B Groebner E Pueblita M Clinical Research - Vesperin-Chlorpromazine Therapy Scientific Papers of the 114th Annual Meeting of the American Psychiatric Association 1958 104 5"},{"issue":"4","key":"10.1002\/14651858.CD000284.pub3-BIB0221|cit221","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/BF00429387","article-title":"Effects of various drugs on flicker fusion frequency. II. Phenothiazine derivatives (with reference to the dependence of the results on the chronological course of experiments","volume":"27","author":"Graupner","year":"1972","journal-title":"Psychopharmacologia"},{"issue":"1","key":"10.1002\/14651858.CD000284.pub3-BIB0222|cit222","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s002130050111","article-title":"A comparison of the sedative and amnestic effects of chlorpromazine and lorazepam","volume":"128","author":"Green","year":"1996","journal-title":"Psychopharmacology"},{"issue":"1,2","key":"10.1002\/14651858.CD000284.pub3-BIB0223|cit223","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0920-9964(97)88594-5","article-title":"Antisaccade and no-saccade distractibilty with chlorpromazine and lorazepam","volume":"29","author":"Green","year":"1998","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0224|cit224","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1176\/ajp.123.2.221","article-title":"Differential effects of abrupt versus gradual withdrawal of chlorpromazine in hospitalized chronic schizophrenic patients","volume":"123","author":"Greenberg","year":"1966","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0225|cit225","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0022-3565(25)31748-9","article-title":"Human drug self-administration: double-blind comparison of pentobarbital, diazepam, chlorpromazine and placebo","volume":"210","author":"Griffiths","year":"1979","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0226|cit226","first-page":"22","article-title":"The incidence of treatment emergent symptoms under chlorpromazine and placebo conditions","volume":"14","author":"Guy","year":"1978","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0227|cit227","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/14640747808400657","article-title":"Laterality, attention and rate effects in the auditory temporal discrimination of chronic schizophrenics - the effect of treatment with chlorpromazine","volume":"30","author":"Hammond","year":"1978","journal-title":"Quarterly Journal of Experimental Psychology"},{"issue":"1","key":"10.1002\/14651858.CD000284.pub3-BIB0228|cit228","first-page":"107","article-title":"Plasma prolactin in schizophrenia subjects treated with seroquel (TM) (ICI 204,636)","volume":"32","author":"Hamner","year":"1996","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0229|cit229","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/archpsyc.1960.01710060089013","article-title":"Denial of illness in schizophrenic outpatients: effects of psychopharmacological treatment","volume":"3","author":"Hankoff","year":"1960","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0230|cit230","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00005053-195807000-00003","article-title":"A comparative study of chlorpromazine and triflupromazine in the management of the chronic hospitalized psychotic patient","volume":"127","author":"Hanlon","year":"1958","journal-title":"Journal of Nervous and Mental Diseases"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0231|cit231","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00005053-196001000-00011","article-title":"The psychiatric physician and the phenothiazine tranquilizers","volume":"130","author":"Hanlon","year":"1960","journal-title":"Journal of Nervous and Mental Diseases"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0232|cit232","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2125.1976.tb03713.x","article-title":"Work performance versus clinical assessment in the evaluation of phenothiazine therapy","volume":"3","author":"Harper","year":"1976","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0233|cit233","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.2044-8295.1978.tb01656.x","article-title":"Chlorpromazine and serial reaction performance","volume":"69","author":"Hartley","year":"1978","journal-title":"British Journal of Psychology"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0234|cit234","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/BF02686641","article-title":"Pharmacological effects on lateralized behavior","volume":"6","author":"Hartley","year":"1987","journal-title":"Current Psychology Research and Reviews"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0235|cit235","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/0031-9384(89)90215-1","article-title":"Lateralization of emotional expression under a neuroleptic drug","volume":"45","author":"Hartley","year":"1989","journal-title":"Physiology and Behavior"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0236|cit236","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/0031-9384(91)90409-H","article-title":"Chlorpromazine and the lateralisation of the perception of emotion","volume":"50","author":"Hartley","year":"1991","journal-title":"Physiology and Behavior"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0237|cit237","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF00423056","article-title":"The effects of long term administration of psychotrophic drugs on human sleep. IV. The effects of chlorpromazine","volume":"33","author":"Hartmann","year":"1973","journal-title":"Psychopharmacologia"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0238|cit238","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/j.1552-4604.1974.tb01368.x","article-title":"A controlled outpatient trial of perphenazine-amitriptyline and chlorpromazine","volume":"14","author":"Haskell","year":"1974","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0239|cit239","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/00005053-195904000-00008","article-title":"The effects of chlorpromazine upon psychomotor and psychiatric behavior of chronic schizophrenic patients","volume":"128","author":"Heilizer","year":"1959","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0240|cit240","first-page":"53","article-title":"Weight changes in relation to the characteristics of patients on chlorpromazine","volume":"20","author":"Planansky","year":"1959","journal-title":"Journal of Clinical and Experimental Psychopathology"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0241|cit241","first-page":"675","article-title":"A controlled study of placebo, chlordiazepoxide and chlorpromazine with thirty male schizophrenic patients","volume":"28","author":"Hekimian","year":"1967","journal-title":"Diseases of the Nervous System"},{"issue":"9","key":"10.1002\/14651858.CD000284.pub3-BIB0242|cit242","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/00005053-198809000-00009","article-title":"High potency neuroleptics and violence in schizophrenics","volume":"176","author":"Herrera","year":"1988","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0243|cit243","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1055\/s-2007-1014469","article-title":"Predictive value of pharmaco electroencephalography in early human pharmacological evaluations of psychoactive drugs - first example - Savoxepine","volume":"24","author":"Herrmann","year":"1991","journal-title":"Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0244|cit244","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1055\/s-2007-1014471","article-title":"Pharmaco EEG profile of maroxepine - third example to discuss the predictive value of pharmaco electroencephalography in early human pharmacological evaluations of psychoactive drugs","volume":"24","author":"Herrmann","year":"1991","journal-title":"Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0245|cit245","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/archpsyc.1991.01810280049007","article-title":"Intermittent versus maintenance medication in schizophrenia. Two-year results","volume":"48","author":"Herz","year":"1991","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0246|cit246","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1177\/070674377502000621","article-title":"Megavitamin treatment of schizophrenia","volume":"20","author":"Hoffer","year":"1975","journal-title":"Canadian Psychiatric Association Journal"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0247|cit247","first-page":"494","article-title":"Drug discontinuation among long term, successfully maintained schizophrenic outpatients","volume":"37","author":"Hogarty","year":"1976","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0248|cit248","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1126\/science.159.3822.1487","article-title":"Chlorpromazine: direct measurement of differential behavioral effect","volume":"159","author":"Hollis","year":"1968","journal-title":"Science"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0249|cit249","first-page":"218","article-title":"Chlorpromazine alone and with reserpine","volume":"83","author":"Hollister","year":"1955","journal-title":"California Medicine"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0250|cit250","first-page":"65","article-title":"Psychiatric use of reserpine and chlorpromazine: results of double-blind studies","volume-title":"Psychopharmacology","author":"Hollister","year":"1956"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0251|cit251","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/00004714-198406000-00003","article-title":"Neuroleptic drug-induced changes in platelet levels","volume":"4","author":"Holt","year":"1984","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0252|cit252","doi-asserted-by":"crossref","unstructured":"Hong W Arvanitis L Reduction of the positive symptoms of schizophrenia by '(ICI 204,636): results from phase II and III clinical trials 9th Congress of the European College of Neuropsychopharmacology; 1996 Sep 21-25; Amsterdam, The Netherlands 1996 78179482","DOI":"10.1016\/0924-977X(96)83185-3"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0253|cit253","doi-asserted-by":"crossref","unstructured":"Hong WW Arvanitis LA The atypical profile of '(ICI 204,636) is supported by the lack of sustained elevation of plasma prolactin in schizophrenic patients 9th Congress of the European College of Neuropsychopharmacology; 1996 Sep 21-25; Amsterdam, The Netherlands 1996 68399894","DOI":"10.1016\/0924-977X(96)83191-9"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0254|cit254","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1136\/bmj.1.4869.1036","article-title":"Action of chlorpromazine and promethazine","volume":"1","author":"Hopkin","year":"1954","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0255|cit255","first-page":"522","article-title":"Therapeutic effects of different modes of chlorpromazine administration","volume":"27","author":"Hrushka","year":"1966","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0256|cit256","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/0006-2952(67)90314-0","article-title":"The effect of antipyretic analgesics on the metabolism of chlorpromazine in man","volume":"16","author":"Huang","year":"1967","journal-title":"Biochemical Pharmacology"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0257|cit257","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1192\/bjp.113.501.867","article-title":"An appraisal of the continuing practice of prescribing tranquillizing drugs for long-stay psychiatric patients","volume":"113","author":"Hughes","year":"1967","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0258|cit258","first-page":"726","article-title":"Chlorpromazine and Pecazine in chronic schizophrenia","volume":"106","author":"Hurst","year":"1960","journal-title":"Journal of Mental Science (British Journal of Psychiatry from 1963)"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0259|cit259","unstructured":"Hurst BC Link C A comparison of the tolerance profile of seroquel with typical neuroleptics and placebo Xth World Congress of Psychiatry. Madrid, Spain Madrid, Spain"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0260|cit260","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1176\/ajp.126.4.570","article-title":"The effect of chlorpromazine on the swallowing function in chronic schizophrenic patients","volume":"126","author":"Hussar","year":"1969","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0261|cit261","unstructured":"IRCT138811022935N3 The effect of omega-3 on negative and positive symptoms in patients with chronic schizophrenia: A DOUBLE BLIND and PLACEBO controlled trial http:\/\/www.irct.ir\/ 2010"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0262|cit262","first-page":"267","article-title":"Differentiation of psychotropic drugs by quantitative EEG analysis","volume":"9","author":"Itil","year":"1968","journal-title":"Agressologie"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0263|cit263","first-page":"195","article-title":"Quantitative pharmaco-electroencephalography in early evaluation of psychotropic drugs","volume":"25","author":"Itil","year":"1971","journal-title":"Folia Psychiatrica et Neurologica Japonica"},{"issue":"5","key":"10.1002\/14651858.CD000284.pub3-BIB0264|cit264","first-page":"80","article-title":"Clinical observation of the treatment of cognitive impairment in schizophrenia by the TCM therapy of enforcing spleen and nourishing kidney","volume":"27","author":"Jia","year":"2004","journal-title":"Journal of Beijing University of TCM"},{"issue":"8069","key":"10.1002\/14651858.CD000284.pub3-BIB0265|cit265","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0140-6736(78)90193-9","article-title":"Mechanism of the antipsychotic effect in the treatment of acute schizophrenia","volume":"1","author":"Johnstone","year":"1978","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0266|cit266","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1192\/bjp.115.524.851","article-title":"Drugs and motor activity in chronic schizophrenia","volume":"115","author":"Jones","year":"1969","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0267|cit267","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1192\/bjp.119.552.545","article-title":"Effects of chlorpromazine and trifluoperazine on the activity of chronic schizophrenics","volume":"119","author":"Jones","year":"1971","journal-title":"British Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD000284.pub3-BIB0268|cit268","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF00427342","article-title":"3-Methoxy-4-hydroxyphenylglycol excretion in acutely schizophrenic patients during a controlled clinical trial of the isomers of flupenthixol","volume":"64","author":"Joseph","year":"1979","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0269|cit269","first-page":"45","article-title":"Vitamins B1, B6, and B12 in the adjunctive treatment of schizophrenia - further studies to examine the effect of reduction of chlorpromazine dosage","volume":"11","author":"Joshi","year":"1980","journal-title":"Journal of Orthomolecular Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD000284.pub3-BIB0270|cit270","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000468574","article-title":"Effect of piracetam on extrapyramidal side effects induced by neuroleptic drugs","volume":"17","author":"Kabes","year":"1982","journal-title":"International Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0271|cit271","first-page":"109","article-title":"Clinical experimentation with desipramine with statistical control","volume":"1","author":"Kammerer","year":"1968","journal-title":"Annales Medico-psychologiques"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0272|cit272","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/archpsyc.1974.01760130044007","article-title":"Effect of prolonged chlorpromazine administration on the sleep of chronic schizophrenics","volume":"31","author":"Kaplan","year":"1974","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0273|cit273","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0033-3182(70)71674-5","article-title":"A comparative study of butaperazine, chlorpromazine and placebo in chronic schizophrenics","volume":"11","author":"Keskiner","year":"1970","journal-title":"Psychosomatics"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0274|cit274","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1176\/ajp.116.11.1023","article-title":"Responses to treatment-refractory chronic schizophrenics to chlorpromazine with concurrent adrenocortical steroid","volume":"116","author":"Kim","year":"1960","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0275|cit275","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/cpt1971125825","article-title":"Comparison of thioridazine and chlorpromazine in doctor's choice research design","volume":"12","author":"Kimbell","year":"1971","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0276|cit276","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1176\/ajp.115.11.1026","article-title":"Comparison of proclorperazine and chlorpromazine in hospitalized chronic schizophrenics","volume":"115","author":"King","year":"1959","journal-title":"American Journal of Psychiatry"},{"issue":"380","key":"10.1002\/14651858.CD000284.pub3-BIB0277|cit277","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1600-0447.1994.tb05833.x","article-title":"Psychomotor impairment and cognitive disturbances induced by neuroleptics","volume":"89","author":"King","year":"1994","journal-title":"Acta Psychiatrica Scandinavica Supplementum"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0278|cit278","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/00005053-197406000-00009","article-title":"Self-administration of medication by psychiatric inpatients","volume":"158","author":"Klein","year":"1974","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0279|cit279","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/00005053-196810000-00010","article-title":"The effects of chlorpromazine and methamphetamine on visual signal-from-noise detection","volume":"147","author":"Kopell","year":"1968","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0280|cit280","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1192\/bjp.114.512.833","article-title":"Clopenthixol: a controlled trial in chronic hospitalised schizophrenic patients","volume":"114","author":"Kordas","year":"1968","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0282|cit281","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1001\/archneurpsyc.1957.02330330111017","article-title":"Relationship between effects of a number of centrally acting drugs and personality","volume":"77","author":"Kornetsky","year":"1957","journal-title":"Archives of Neurology and Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0281|cit282","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1001\/archneurpsyc.1957.02330330104016","article-title":"Comparison of psychological effects of certain centrally acting drugs in man","volume":"77","author":"Kornetsky","year":"1957","journal-title":"Archives of Neurology and Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0283|cit283","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1001\/archneurpsyc.1957.02330330114018","article-title":"Effects of centrally acting drugs on two tests of brain damage","volume":"77","author":"Primac","year":"1957","journal-title":"Archives of Neurology and Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0284|cit284","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1192\/bjp.104.437.1093","article-title":"Psychological effects of centrally acting drugs in man","volume":"104","author":"Kornetsky","year":"1958","journal-title":"Journal of Mental Science"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0285|cit285","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00005053-195901000-00002","article-title":"The effects of chlorpromazine and secobarbital on the C.P.T","volume":"128","author":"Mirsky","year":"1959","journal-title":"Journal of Nervous and Mental Diseases"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0286|cit286","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1192\/bjp.105.438.190","article-title":"A comparison of the psychological effects of acute and chronic administration of chlorpromazine and secobarbital (quinalbarbitone) in schizophrenic patients","volume":"105","author":"Kornetsky","year":"1959","journal-title":"Journal of Mental Science"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0287|cit287","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/cpt196565587","article-title":"Effects of chronic chlorpromazine administration on systemic arterial pressure in schizophrenic patients: relationship of body position to blood pressure","volume":"6","author":"Korol","year":"1965","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0288|cit288","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/archneurpsyc.1955.02330170001001","article-title":"A comparison of chlorpromazine and reserpine in chronic psychosis","volume":"74","author":"Kovitz","year":"1955","journal-title":"Archives of Neurology and Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0289|cit289","first-page":"839","article-title":"A double-blind evaluation of metiapine in hospitalized acute schizophrenics","volume":"18","author":"Kramer","year":"1975","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0290|cit290","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0165-1781(80)90008-6","article-title":"The influence of chlorpromazine and amylobarbitone on the recovery limb of the electrodermal response","volume":"2","author":"Kugler","year":"1980","journal-title":"Psychiatry Research"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0291|cit291","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/archpsyc.1971.01750080089015","article-title":"Chlorpromazine and sleep in psychiatric patients","volume":"24","author":"Kupfer","year":"1971","journal-title":"Archives of General Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD000284.pub3-BIB0292|cit292","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/j.1552-4604.1981.tb01730.x","article-title":"Viloxazine and the depressed schizophrenic - methodological issues","volume":"21","author":"Kurland","year":"1981","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0293|cit293","first-page":"300","article-title":"A double blind study of clomacran","volume":"11","author":"Lampe","year":"1969","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0294|cit294","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF00403631","article-title":"The effects of chlorpromazine and secobarbital under two conditions of reinforcement on the performance of chronic schizophrenic subjects","volume":"7","author":"Latz","year":"1965","journal-title":"Psychopharmacologia"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0295|cit295","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1055\/s-2007-1019598","article-title":"Relationship between plasma-levels of chlorpromazine and effects on EEG and evoked potentials in healthy volunteers","volume":"14","author":"Laurian","year":"1981","journal-title":"Pharmacopsychiatria"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0297|cit296","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/bmj.4.5885.156","article-title":"Influence of selection of patients on results of clinical trials","volume":"4","author":"Leff","year":"1973","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0296|cit297","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1136\/bmj.3.5775.599","article-title":"Trial of maintenance therapy in schizophrenia","volume":"3","author":"Leff","year":"1971","journal-title":"British Medical Journal"},{"issue":"1","key":"10.1002\/14651858.CD000284.pub3-BIB0298|cit298","first-page":"55","article-title":"Natural human leukocyte interferon in the treatment of schizophrenia","volume":"5","author":"Leszek","year":"1991","journal-title":"European Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0299|cit299","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1037\/h0045486","article-title":"A comparison of the effects of phenobarbital, promethazine, chlorpromazine, and placebo upon mental hospital patients","volume":"23","author":"Levin","year":"1959","journal-title":"Journal of Consulting Psychology"},{"issue":"1","key":"10.1002\/14651858.CD000284.pub3-BIB0300|cit300","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0920-9964(97)00034-0","article-title":"Immediate effects of chlorpromazine and perphenazine following neuroleptic washout on word association of schizophrenic patients","volume":"26","author":"Levine","year":"1997","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0301|cit301","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/00221309.1961.9920469","article-title":"Effects of chlorpromazine and promazine on perseveration","volume":"65","author":"Levita","year":"1961","journal-title":"Journal of General Psychology"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0302|cit302","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/00048677309161478","article-title":"Haloperidol and chlorpromazine - a double-blind cross-over trial and clinical study in children and adolescents","volume":"7","author":"Lewis","year":"1973","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD000284.pub3-BIB0303|cit303","first-page":"747","article-title":"Ziprasidone in treatment of schizophrenia: a double blind, randomized, controlled, parallel group, and multicenter study","volume":"25","author":"Li","year":"2006","journal-title":"Chinese Journal of New Drugs and Clinical Remedies [\u4e2d\u56fd\u65b0\u836f\u4e0e\u4e34\u5e8a\u6742\u5fd7]"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0304|cit304","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/00005053-197306000-00009","article-title":"Research design for analyzing drug-environment-behavior interactions","volume":"156","author":"Liberman","year":"1973","journal-title":"Journal of Nervous and Mental Diseases"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0305|cit305","first-page":"334","article-title":"A double-blind controlled comparison of the effects of Chlorpromazine, Barbiturate and a placebo in 142 chronic psychotic in-patients","volume":"4","author":"Little","year":"1958","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0306|cit306","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1192\/bjp.114.512.843","article-title":"Treatment of acute mental disorders with an adrenal steroid","volume":"114","author":"Loranger","year":"1968","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0307|cit307","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/archpsyc.1961.01710100061007","article-title":"Meprobamate and chlorpromazine in psychotherapy. Some effects on anxiety and hostility of outpatients","volume":"4","author":"Lorr","year":"1961","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0308|cit308","first-page":"71","article-title":"The use of chlorpromazine as an activating agent","volume":"8","author":"Lyberi","year":"1956","journal-title":"Electroencephalography and Clinical Neurophysiology"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0309|cit309","first-page":"164","article-title":"Comparison of diazepam, chlorprothixine and chlorpromazine in chronic schizophrenic patients","volume":"25","author":"Maculans","year":"1964","journal-title":"Diseases of the Nervous System"},{"issue":"4","key":"10.1002\/14651858.CD000284.pub3-BIB0310|cit310","first-page":"283","article-title":"Double blind controlled study of brahmyadiyoga and tagara in the management of various types of unmada (schizophrenia)","volume":"18","author":"Mahal","year":"1976","journal-title":"Indian Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD000284.pub3-BIB0311|cit311","first-page":"37","article-title":"Results of treatment of schizophrenic psychoses with neuroleptics combined with subcomatic insulin","volume":"2","author":"Majewski","year":"1968","journal-title":"Psychiatria Polska"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0312|cit312","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/070674376901400412","article-title":"Integrated EEG variability - drug effects in acute schizophrenics","volume":"14","author":"Marjerrison","year":"1969","journal-title":"Canadian Psychiatric Association Journal"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0313|cit313","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1176\/ajp.128.7.886","article-title":"Perceptual challenge to measure illness and therapy","volume":"128","author":"Marrazzi","year":"1972","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0315|cit314","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1176\/ajp.114.2.173-a","article-title":"Perphenazine - a drug modifying consciousness","volume":"114","author":"Mason-Browne","year":"1957","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0314|cit315","first-page":"300","article-title":"Effect of perphenazine (Trilafon) on modification of crude consciousness","volume":"18","author":"Mason-Browne","year":"1957","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0316|cit316","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1192\/bjp.138.3.271a","article-title":"Phenothiazine withdrawal in schizophrenics in a hostel (letter)","volume":"138","author":"Mathur","year":"1981","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0317|cit317","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF00192551","article-title":"Suriclone enhances the actions of chlorpromazine on human psychomotor performance but not on memory or plasma prolactin in healthy subjects","volume":"46","author":"Mattila","year":"1994","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0318|cit318","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1365-2125.1990.tb05444.x","article-title":"A comparison of the central nervous system effects of haloperidol, chlorpromazine and sulpiride in normal volunteers","volume":"30","author":"McClelland","year":"1990","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"5","key":"10.1002\/14651858.CD000284.pub3-BIB0319|cit319","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/070674376601100507","article-title":"Abrupt withdrawal of chlorpromazine and thioridazine from schizophrenic in-patients","volume":"11","author":"Melnyk","year":"1966","journal-title":"Canadian Psychiatric Association Journal"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0320|cit320","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1176\/ajp.113.11.988","article-title":"Chlorpromazine and chronic neurotic tension","volume":"113","author":"Merry","year":"1957","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0321|cit321","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1177\/009127006600600203","article-title":"Chlorpromazine-chlordiazepoxide and chlorpromazine-imipramine treatment: side effects and clinical laboratory findings","volume":"6","author":"Kurland","year":"1966","journal-title":"Journal of New Drugs"},{"issue":"supplement","key":"10.1002\/14651858.CD000284.pub3-BIB0322|cit322","first-page":"117","article-title":"Chlorpromazine-chlordiazepoxide and chlorpromazine-imipramine treatment of newly hospitalized, acutely ill psychiatric patients","volume":"8","author":"Michaux","year":"1966","journal-title":"Current Therapeutic Research, Clinical and Experimental"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0323|cit323","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1192\/bjp.109.460.428","article-title":"A trial of fluphenazine in schizophrenia","volume":"109","author":"Millar","year":"1963","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0324|cit324","first-page":"1105","article-title":"A clinical trial of Largactil (chlorpromazine), Stemeticl (prochlorperazine) and Veractil (methotrimeprazine)","volume":"106","author":"Milne","year":"1960","journal-title":"British Journal of Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD000284.pub3-BIB0325|cit325","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/0006-3223(94)90861-3","article-title":"Pharmaco-eeg studies of single doses of an atypical neuroleptic iloperidone, compared with chlorpromazine and PLACEBO in schizophrenic-patients","volume":"35","author":"Milstein","year":"1994","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0326|cit326","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.2044-8341.1978.tb02456.x","article-title":"Confrontation versus belief modification in persistently deluded patients","volume":"51","author":"Milton","year":"1978","journal-title":"British Journal of Medical Psychology"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0327|cit327","first-page":"151","article-title":"Chlorpromazine in the treatment of the chronic disturbed schizophrenic patient","volume":"102","author":"Mitchell","year":"1956","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0328|cit328","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/1097-4679(196010)16:4<440::AID-JCLP2270160434>3.0.CO;2-A","article-title":"Psychological response to chlorpromazine in a group of psychiatric patients","volume":"16","author":"Mitchell","year":"1960","journal-title":"Journal of Clinical Psychology"},{"issue":"12","key":"10.1002\/14651858.CD000284.pub3-BIB0329|cit329","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0006-3223(98)00270-4","article-title":"Prolactin hyperresponsiveness to D fenfluramine in drug free schizophrenic patients: a placebo controlled study","volume":"45","author":"Monteleone","year":"1999","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0330|cit330","first-page":"254","article-title":"Comparative short-term evaluation of triflupromazine hydrochloride, chlorpromazine hyrochloride, and placebo in acutely disturbed patients","volume":"60","author":"Morgenstern","year":"1960","journal-title":"New York State Journal of Medicine"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0331|cit331","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1176\/ajp.124.11.1585","article-title":"A study of the withdrawal of chlorpromazine or trifluoperazine in chronic schizophrenia","volume":"124","author":"Morton","year":"1968","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0332|cit332","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1176\/ajp.115.5.449","article-title":"Specific behavioural changes produced by chlorpromazine in chronic schizophrenia","volume":"115","author":"Moss","year":"1958","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0333|cit333","first-page":"367","article-title":"A comparative trial of oxypertine and chlorpromazine in chronic schizophrenia","volume":"11","author":"Neal","year":"1969","journal-title":"Current Therapeutic Research - Clinical and Experimental"},{"issue":"3","key":"10.1002\/14651858.CD000284.pub3-BIB0334|cit334","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00005053-195603000-00008","article-title":"The use of chlorpromazine in psychotherapy","volume":"123","author":"Newbold","year":"1956","journal-title":"Journal of Nervous and Mental Diseases"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0335|cit335","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF00431111","article-title":"A preliminary double-blind study on the efficacy of carbamazepine in prophylaxis of manic-depressive illness","volume":"73","author":"Okuma","year":"1981","journal-title":"Psychopharmacology Berlin"},{"issue":"2","key":"10.1002\/14651858.CD000284.pub3-BIB0336|cit336","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/cpt1969102258","article-title":"A comparison of the behavioral effects of periodic administration of chlorpromazine and a \"sustained-release\" form of chlorpromazine","volume":"10","author":"Orzack","year":"1969","journal-title":"Clinical Pharamacology and Therapeutics"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0337|cit337","first-page":"1705","article-title":"Use of psychological methods for studying the particular psychotropic action of various psychopharmacologic drugs","volume":"72","author":"Osmakova","year":"1972","journal-title":"Zhurnal Nevropatologii i Psikhiatrii"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0338|cit338","unstructured":"Rojo-Sierra M Alonso J D\u00edez E Giner J Lloret E 5th World Congress of Psychiatry; 1971 Nov 28 - Dec 4; Ciudad de Mexico, Mexico 1971 79081577"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0339|cit339","unstructured":"Pai Y-M Yu S-C Lin C-C Risperidone in reducing tardive dyskinesia: a double-blind, placebo-controlled study Annual Meeting of the American Psychiatric Association; 2001 May 5-10; LA, USA Marathon Multimedia 2001 98017426"},{"issue":"2","key":"10.1002\/14651858.CD000284.pub3-BIB0340|cit340","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00005053-196602000-00006","article-title":"Clinical judgment in the assessment of psychopharmacological effects","volume":"142","author":"Paredes","year":"1966","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0341|cit341","first-page":"929","article-title":"Effects of triiodothyronine and chlorpromazine combination treatment in schizophrenia","volume":"29","author":"Park","year":"1981","journal-title":"Current Therapeutic Research - Clinical and Experimental"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0342|cit342","volume-title":"Schizophrenics in the Community: an Experimental Study in the Prevention of Hospitalization","author":"Pasamanick","year":"1967"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0343|cit343","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF00431103","article-title":"Bilateral skin conductance and the pupillary light dark reflex - manipulation by chlorpromazine, haloperidol, scopolamine, and placebo","volume":"73","author":"Patterson","year":"1981","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0344|cit344","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0140-6736(80)92135-2","article-title":"Pharmacokinetic interaction between propranolol and chlorpromazine in schizophrenic patients [letter]","volume":"2","author":"Peet","year":"1980","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0345|cit345","first-page":"42","article-title":"A two-year comparative study of ataraxics in neuropsychiatric patients","volume":"5","author":"Pennington","year":"1957","journal-title":"Journal of the American Geriatric Association"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0346|cit346","first-page":"518","article-title":"Long-term medication in schizophrenia","volume":"49","author":"Pietzcker","year":"1978","journal-title":"Nervenarzt"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0348|cit347","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0920-9964(93)90075-T","article-title":"The clinical relevance of an auditory attention task (PAT) in a longitudinal study of chronic schizophrenia, with placebo substitution for chlorpromazine","volume":"10","author":"Pigache","year":"1993","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0347|cit348","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1042\/cs044028Pa","article-title":"Measurement of drug action in schizophrenia","volume":"44","author":"Pigache","year":"1973","journal-title":"Clinical Science"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0349|cit349","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0920-9964(93)90076-U","article-title":"Effects of placebo, orphenadrine, and rising doses of chlorpromazine, on PAT performance in chronic schizophrenia. A two-year longitudinal study","volume":"10","author":"Pigache","year":"1993","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0350|cit350","first-page":"601","article-title":"Selective drug action related to chronic schizophrenic subtype. (A comparative study of carphenazine, chlorpromazine, and trifluoperazine)","volume":"28","author":"Platz","year":"1967","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0351|cit351","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF01564324","article-title":"Chlorpromazine (Thorazine) for mental illness in the presence of pulmonary tuberculosis","volume":"30","author":"Pleasure","year":"1956","journal-title":"Psychiatry Quarterly"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0352|cit352","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1176\/ajp.112.11.937","article-title":"The effect of chlorpromazine on the return rate of 250 patients released from the Rochester State Hospital","volume":"112","author":"Pollack","year":"1956","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0353|cit353","first-page":"427","article-title":"Combined effects of chlorpromazine and meprobamate in chronically disturbed psychotic patients","volume":"20","author":"Pollard","year":"1959","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0354|cit354","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1177\/026988119601000210","article-title":"The effect of chlorpromazine and benzhexol on memory and psychomotor function in healthy volunteers","volume":"10","author":"Quigley","year":"1996","journal-title":"Journal of Psychopharmacology"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0355|cit355","first-page":"161","article-title":"A comparative controlled trial of methotrimeprazine ('veractil') in chronic schizophrenia","volume":"106","author":"Quinn","year":"1960","journal-title":"British Journal of Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD000284.pub3-BIB0356|cit356","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s002280000192","article-title":"Ciprofloxacin increases serum clozapine and N-desmethylclozapine: a study in patients with schizophrenia","volume":"56","author":"Raaska","year":"2000","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0357|cit357","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0021-9681(68)90007-6","article-title":"The evaluation of chlorpromazine therapy in chronic schizophrenic women. A replicated experiment","volume":"21","author":"Ragland","year":"1968","journal-title":"Journal of Chronic Diseases"},{"issue":"2","key":"10.1002\/14651858.CD000284.pub3-BIB0358|cit358","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0163-8343(00)00055-4","article-title":"Second generation antipsychotics in the emergency care setting. A prospective naturalistic study","volume":"22","author":"Raja","year":"2000","journal-title":"General Hospital Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0359|cit359","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/archpsyc.1967.01730250099014","article-title":"Competing voice messages. Effects of message load and drugs on the ability of acute schizophrenics to attend","volume":"17","author":"Rappaport","year":"1967","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0360|cit360","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/00005053-196805000-00005","article-title":"Attention to competing voice messages by nonacute schizophrenic patients. Effects of message load, drugs, dosage levels and patient background","volume":"146","author":"Rappaport","year":"1968","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0361|cit361","first-page":"705","article-title":"A controlled study of the prognostic significance of autonomic responses in the chlorpromazine treatment of disturbed psychotic patients","volume":"104","author":"Rathod","year":"1958","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0362|cit362","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/bmj.2.5036.63","article-title":"A trial of five tranquillizing drugs in psychoneurosis","volume":"2","author":"Raymond","year":"1957","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0363|cit363","first-page":"179","article-title":"The effects of chlorpromazine on fine psychomotor performance with a simultaneous secondary task in schizophrenics","volume":"13","author":"Remr","year":"1971","journal-title":"Activitas Nervosa Superior"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0364|cit364","first-page":"253","article-title":"The effects of chlorpromazine on some components of psychomotor performance in schizophrenics","volume":"12","author":"Remr","year":"1970","journal-title":"Activitas Nervosa Superior"},{"issue":"4","key":"10.1002\/14651858.CD000284.pub3-BIB0365|cit365","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1001\/archpsyc.1978.01770280093010","article-title":"Are prophylactic antiparkinson drugs necessary? A controlled study of procyclidine withdrawal","volume":"35","author":"Rifkin","year":"1978","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0366|cit366","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1176\/ajp.112.9.678","article-title":"Clinical evaluation of azacyclonol, chlorpromazine, and reserpine on a group of chronic psychotic patients","volume":"112","author":"Rinaldi","year":"1956","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0367|cit367","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/cpt1973146978","article-title":"Effects of mode of management on plasma chlorpromazine in psychiatric patients","volume":"14","author":"Rivera Calimlim","year":"1973","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0368|cit368","unstructured":"Rojo-Sierra M Alonso J D\u00edez E Giner J Lloret E 5th World Congress of Psychiatry; 1971 Nov 28 - Dec 4; Ciudad de Mexico, Mexico 1971 495 6 79081577"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0369|cit369","first-page":"271","article-title":"Prediction of psychiatric hospitalization. II. The Hospitalization Proneness Scale: a cross-validation","volume":"80","author":"Rosen","year":"1972","journal-title":"Journal of Nervous and Mental Disease"},{"issue":"9","key":"10.1002\/14651858.CD000284.pub3-BIB0370|cit370","doi-asserted-by":"crossref","first-page":"671","DOI":"10.4088\/JCP.v61n0913","article-title":"Clinical and psychopharmacologic factors influencing family burden in refractory schizophrenia","volume":"61","author":"Rosenheck","year":"2000","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0371|cit371","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/00005053-195512000-00001","article-title":"A comparative study of the effect on anxiety of chlorpromazine, reserpine, phenobarbital, and a placebo","volume":"122","author":"Rosner","year":"1955","journal-title":"Journal of Nervous and Mental Diseases"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0372|cit372","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1176\/ajp.113.11.979","article-title":"Clinical evaluation of two phenothiazine compounds Promazine and Mepazine","volume":"113","author":"Rudy","year":"1957","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0373|cit373","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1176\/ajp.115.4.364","article-title":"Trifluoperazine in the treatment of psychotic patients","volume":"115","author":"Rudy","year":"1958","journal-title":"American Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD000284.pub3-BIB0374|cit374","first-page":"14","article-title":"Chlorpromazine in psychiatric disorders","volume":"2","author":"Sainz","year":"1955","journal-title":"Prescriber"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0375|cit375","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF00402529","article-title":"Effect of minor and major tranquilizers on somatosensory evoked potentials","volume":"24","author":"Saletu","year":"1972","journal-title":"Psychopharmacologia"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0376|cit376","first-page":"830","article-title":"Ritalin and chlorpromazine in chronic schizophrenia: a controlled clinical trial","volume":"103","author":"Salisbury","year":"1957","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0377|cit377","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/BF01575453","article-title":"Comparison of low and high dosage procedures in chlorpromazine therapy","volume":"33","author":"Schiele","year":"1959","journal-title":"Psychiatric Quarterly"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0378|cit378","first-page":"200","article-title":"Combined treatment with chlorpromazine and reserpine: an attempt at quantitative assessments in chronic schizophrenic patients","volume":"103","author":"Schmidt","year":"1957","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0379|cit379","first-page":"157","article-title":"Relationships among clinical response, extrapyramidal syndrome and plasma chlorpromazine and metabolite ratios","volume":"1","author":"Sakalis","year":"1977","journal-title":"Communucations in Psychopharmacology"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0381|cit380","first-page":"30","article-title":"Chlorpromazine metabolism and clinical response in acute schizophrenia - a preliminary report","volume":"11","author":"Schooler","year":"1975","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0380|cit381","first-page":"199","article-title":"Chlorpromazine metabolism and clinical response in acute schizophrenia - a preliminary report","volume-title":"Pharmacokinetics of Psychoactive Drugs","author":"Schooler","year":"1976"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0382|cit382","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1136\/bmj.1.4918.882","article-title":"Chlorpromazine in treatment of elderly psychotic women","volume":"1","author":"Seager","year":"1955","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0383|cit383","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000467995","article-title":"Consistency and similarity of drug EEG responses in chronic schizophrenic patients","volume":"8","author":"Serafetinides","year":"1973","journal-title":"International Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0384|cit384","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1176\/ajp.134.5.512","article-title":"Platelet monoamine oxidase activity in schizophrenic patients","volume":"134","author":"Becker","year":"1977","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0385|cit385","first-page":"29","article-title":"Blood platelet monoamine oxidase activity in anergic schizophrenics","volume":"3","author":"Shaskan","year":"1975","journal-title":"National Institute of Drug Abuse Research Monograph Services"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0386|cit386","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/253659b0","article-title":"Platelet monoamine oxidase in schizophrenics","volume":"253","author":"Shaskan","year":"1975","journal-title":"Nature"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0387|cit387","first-page":"452","article-title":"Comparison of chlorpromazine and reserpine in maintenance drug therapy","volume":"20","author":"Shawver","year":"1959","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0388|cit388","first-page":"12","article-title":"Clozapine: double-blind control trial in the treatment of acute schizophrenia","volume":"14","author":"Shopsin","year":"1978","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0389|cit389","first-page":"77","article-title":"Clozapine: antipsychotic activity in treatment-resistant schizophrenics","volume":"1","author":"Honigfeld","year":"1984","journal-title":"Advances in Therapy"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0390|cit390","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/archpsyc.1979.01780060047005","article-title":"Clozapine, chlorpromazine, and placebo in newly hospitalized, acutely schizophrenic patients","volume":"36","author":"Shopsin","year":"1979","journal-title":"Archives of General Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD000284.pub3-BIB0391|cit391","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00004850-200015050-00002","article-title":"Fluvoxamine augmentation of antipsychotics improves negative symptoms in psychotic chronic schizophrenic patients: a placebo-controlled study","volume":"15","author":"Silver","year":"2000","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0392|cit392","unstructured":"Simopoulos AM Pinto A Uhlenhuth EH Mcgee J Old wine in new bottles: decreased hostility in chronic psychotic inpatients treated with diphenylhydantoin (Dilantin) 5th World Congress of Psychiatry. Ciudad de Mexico Ciudad de Mexico 1971 abstract 1077"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0393|cit393","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/cpt1974156631","article-title":"Bioequivalency of generic and brand-named chlorpromazine","volume":"15","author":"Simpson","year":"1974","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0394|cit394","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1001\/archpsyc.1980.01780150095010","article-title":"Effect of antiparkinsonian medication on plasma levels of chlorpromazine","volume":"37","author":"Simpson","year":"1980","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0397|cit395","first-page":"191","article-title":"Dysphoric response to neuroleptic treatment in schizophrenia and its prognostic significance","volume":"37","author":"Singh","year":"1976","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0398|cit396","first-page":"173","article-title":"Dysphoric response to neuroleptic treatment in schizophrenia and its prognostic significance","volume":"2","author":"Singh","year":"1974","journal-title":"Journal of the Bronx State Hospital"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0395|cit397","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00421012","article-title":"A comparative study of haloperidol and chlorpromazine in terms of clinical effects and therapeutic reversal with benzotropine in schizophrenia. Theoretical implications for potency differences among neuroleptics","volume":"43","author":"Singh","year":"1975","journal-title":"Psychopharmacologia"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0396|cit398","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/00005053-197504000-00005","article-title":"Therapeutic reversal with benztropine in schizophrenics: practical and theoretical significance","volume":"160","author":"Singh","year":"1975","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0399|cit399","first-page":"319","article-title":"Neuroleptic withdrawal in patients meeting criteria for supersensitivity psychosis","volume":"51","author":"Singh","year":"1990","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0400|cit400","first-page":"124","article-title":"Computerized EEG profiles of haloperidol, chlorpromazine, clozapine and placebo in treatment resistant schizophrenia","volume":"18","author":"Small","year":"1987","journal-title":"Clinical Electroencephalography"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0401|cit401","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1176\/ajp.115.3.253","article-title":"A comparison of triflupromazine (Vesprin), chlorpromazine and placebo in 85 chronic patients","volume":"115","author":"Smith","year":"1958","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0402|cit402","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1176\/ajp.117.4.362","article-title":"A comparative controlled study with chlordiazepoxide","volume":"117","author":"Smith","year":"1960","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0403|cit403","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/00005053-196704000-00006","article-title":"ECT-chlorpromazine and chlorpromazine compared in the treatment of schizophrenia","volume":"144","author":"Smith","year":"1967","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0404|cit404","first-page":"16","article-title":"Chlorpromazine: a controlled study with highly disturbed patients","volume":"18","author":"Sommerness","year":"1957","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0405|cit405","first-page":"514","article-title":"Controlled trial of Prochlorperazine (Stemetil) in schizophrenia","volume":"107","author":"South-East Region (Scotland) Therapeutic Trials Committee","year":"1961","journal-title":"Journal of Mental Science (British Journal of Psychiatry from 1963)"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0406|cit406","first-page":"526","article-title":"The effect of psychopharmacological drugs and other central nervous system effecting drugs on experimental nystagmus","volume":"36","author":"Soyka","year":"1968","journal-title":"Fortschritte Der Neurologie, Psychiatrie Und Ihrer Grenzgebiete"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0407|cit407","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00005053-196702000-00004","article-title":"The effects of carphenazine, trifluoperazine and chlorpromazine on ward behavior, physiological functioning and psychological test scores in chronic schizophrenic patients","volume":"144","author":"Spiegel","year":"1967","journal-title":"Journal of Nervous and Mental Diseases"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0408|cit408","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/00005053-197409000-00008","article-title":"The effect of chlorpromazine on visual information processing in normal subjects","volume":"159","author":"Spohn","year":"1974","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0409|cit409","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1176\/ajp.121.12.1147","article-title":"Time-series frequency analysis, and electrogenesis of the EEGs of normals and psychotics before and after drugs","volume":"122","author":"Pfeiffer","year":"1965","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0410|cit410","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1001\/archpsyc.1964.01720220018005","article-title":"EEG and behavioural changes in schizophrenia","volume":"10","author":"Sugerman","year":"1964","journal-title":"Archives of General Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD000284.pub3-BIB0411|cit411","first-page":"90","article-title":"Venlafaxine combined with chlorpromazine in treating negative symptoms of schizophrenia","volume":"39","author":"Sun","year":"2006","journal-title":"Chinese Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD000284.pub3-BIB0412|cit412","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/030006059702500104","article-title":"Citalopram causes no significant alterations in plasma neuroleptic levels in schizophrenic patients","volume":"25","author":"Syvalahti","year":"1997","journal-title":"Journal of International Medical Research"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0413|cit413","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1176\/ajp.121.6.597","article-title":"Are tranquilizer combinations more effective than a single tranquilizer?","volume":"121","author":"Talbot","year":"1964","journal-title":"American Journal of Psychiatry"},{"issue":"12","key":"10.1002\/14651858.CD000284.pub3-BIB0414|cit414","first-page":"1750","article-title":"Improving the memory impairment of schizophrenia patients by strengthening the spleen and invigorating the kidney","volume":"18","author":"Tang","year":"2005","journal-title":"Chinese Journal of the Practical Chinese with Modern Medicine [\u4e2d\u534e\u5b9e\u7528\u4e2d\u897f\u533b\u6742\u5fd7]"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0415|cit415","unstructured":"Tang YY Jia HX Jiang ZK Cao XD Yuan HN Zhang JZ Clinical observation of Jian-Pi-Bu-Shen (TCM) treating memory deterioration in patients with schizophrenia Proceedings of the 8th Conference of Integrated Traditional Chinese Medicine and Western Medicine for Mental Health Problems 2005 32 4"},{"issue":"39","key":"10.1002\/14651858.CD000284.pub3-BIB0416|cit416","first-page":"10","article-title":"Attention impairment in patients with schizophrenia after the treatment of strengthening the spleen and invigorating the kidney","volume":"10","author":"Tang","year":"2006","journal-title":"Modern Rehabilitation [\u73b0\u4ee3\u5eb7\u590d]"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0417|cit417","first-page":"135","article-title":"Full coma Insulin therapy, chlorpromazine and electoconvulsive treatment. A control study of 600 schizophrenic patients","volume":"14","author":"Tassis","year":"1959","journal-title":"Medical journal of Malaya"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0418|cit418","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/00048677509159857","article-title":"Tranquilizers or anti-depressants for chronic schizophrenics: a long-term study","volume":"9","author":"Teja","year":"1975","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0419|cit419","first-page":"81","article-title":"A controlled study of chlorpromazine therapy in chronic psychotic patients","volume":"17","author":"Tenenblatt","year":"1956","journal-title":"Journal of Clinical & Experimental Psychopathology"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0420|cit420","first-page":"24","article-title":"No English title available","volume":"23","author":"Terminska","year":"1989","journal-title":"Psychiatria Polska"},{"issue":"2","key":"10.1002\/14651858.CD000284.pub3-BIB0421|cit421","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1177\/070674376901400212","article-title":"Comparative study of fluphenazine ethanate, fluphenazine bichlorhydrate and placebos in chronic schizophrenics","volume":"14","author":"Tetreault","year":"1969","journal-title":"Canadian Psychiatric Association Journal"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0422|cit422","first-page":"790","article-title":"A research method to assess a new tranquillizing drug","volume":"102","author":"Thorpe","year":"1956","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0423|cit423","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1001\/archneurpsyc.1958.02340040112012","article-title":"Chlorpromazine and communication processes","volume":"79","author":"Tourlentes","year":"1958","journal-title":"A.M.A. Archives of Neurology and Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0424|cit424","first-page":"11","article-title":"Maintenance phenothiazines in aftercare of schizophrenic patients","volume":"2","author":"Troshinsky","year":"1962","journal-title":"Pennsylvania Psychiatric Bulletin"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0425|cit425","first-page":"177","article-title":"Changes in the electroencephalogram, the electrodermogram, and the electromyogram provoked by chlorpromazine in man","volume":"20","author":"Turner","year":"1956","journal-title":"Abstracts of World Medicine"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0426|cit426","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.2042-7158.1966.tb07825.x","article-title":"A comparison of fluphenazine and chlorpromazine on critical flicker fusion frequency","volume":"18","author":"Turner","year":"1966","journal-title":"Journal of Pharmacy and Pharmacology"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0427|cit427","first-page":"260","article-title":"Clinical trial of promazine hydrochloride and acetylpromazine in chronic schizophrenic patients","volume":"105","author":"Urquhart","year":"1959","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0428|cit428","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0010-440X(75)90052-8","article-title":"Biochemical versus psychopathological action profile of neuroleptics. A comparative study of chlorpromazine and oxypertine in acute psychotic disorders","volume":"16","author":"Praag","year":"1975","journal-title":"Comprehensive Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0429|cit429","first-page":"81","article-title":"The dopamine hypothesis of schizophrenia. Some direct observations","volume-title":"On the Origin of Schizophrenic Psychoses","author":"Praag","year":"1975"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0430|cit430","unstructured":"Vestre ND An experimental study of the effects of chlorpromazine on association learning in schizophrenic patients Dissertation Abstracts 1961 2374"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0431|cit431","first-page":"247","article-title":"Whom do neuroleptic drugs help?","volume-title":"Psychopharmacology, Sexual Disorders and Drug Abuse","author":"Vinar","year":"1973"},{"issue":"3","key":"10.1002\/14651858.CD000284.pub3-BIB0432|cit432","first-page":"176","article-title":"Schizophrenic syndromes improving without neuroleptic drug treatment","volume":"72","author":"Vinar","year":"1976","journal-title":"Ceskoslovenska Psychiatrie"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0433|cit433","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0165-1781(83)90071-9","article-title":"Short-lived effect of (des-tyr)-gamma-endorphin in schizophrenia","volume":"10","author":"Volavka","year":"1983","journal-title":"Psychiatry Research"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0434|cit434","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1600-0447.1996.tb10653.x","article-title":"Electrocardiographic changes in patients receiving neuroleptic medication","volume":"93","author":"Warner","year":"1996","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0435|cit435","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1192\/bjp.114.506.111","article-title":"The use of pericyazine and chlorpromazine with disturbed mentally subnormal patients","volume":"114","author":"Weir","year":"1968","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0436|cit436","first-page":"113","article-title":"No English title available","volume":"14","author":"Welbel","year":"1980","journal-title":"Psychiatria Polska"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0437|cit437","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1037\/h0049027","article-title":"The effects of chlorpromazine on learning in chronic psychotics","volume":"22","author":"Whitehead","year":"1958","journal-title":"Journal of Consulting Psychology"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0438|cit438","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/00005053-196209000-00005","article-title":"Some psychophysiological effects of chlorpromazine on emotionally disturbed children","volume":"135","author":"Wilcott","year":"1962","journal-title":"Journal of Nervous and Mental Diseases"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0439|cit439","first-page":"90","article-title":"A double-blind trial to investigate the effects of thorazine (largactil, chlorpromazine), compazine (stemetil, prochlorperazine) and stelazine (trifluoperazine) in paranoid schizophrenia","volume":"107","author":"Wilson","year":"1961","journal-title":"British Journal of Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD000284.pub3-BIB0440|cit440","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1176\/ajp.113.11.961","article-title":"An appraisal of chlorpromazine. General principles for administration of chlorpromazine, based on experience with 1,090 patients","volume":"113","author":"Winkelman","year":"1957","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0441|cit441","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1037\/h0040207","article-title":"The short-term effects of chlorpromazine on psychiatric patients","volume":"20","author":"Winter","year":"1956","journal-title":"Journal of Consulting Psychology"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0442|cit442","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1600-0447.1977.tb00229.x","article-title":"Effect of chlorpromazine treatment on prolactin levels in cerebrospinal fluid and plasma of psychotic patients","volume":"56","author":"Wode-Helgodt","year":"1977","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0443|cit443","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1176\/ajp.116.5.461","article-title":"A long term evaluation of chlorpromazine in six chronic schizophrenic patients","volume":"116","author":"Wold","year":"1959","journal-title":"American Journal of Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD000284.pub3-BIB0444|cit444","first-page":"487","article-title":"Triiodothyronine and phenothiazines in schizophrenia","volume":"30","author":"Wolpert","year":"1969","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0445|cit445","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1017\/S0033291796004345","article-title":"Long-term morbidity associated with delayed treatment of first admission schizophrenic patients: a re-analysis of the Camarillo State Hospital data","volume":"27","author":"Wyatt","year":"1997","journal-title":"Psychological Medicine"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0446|cit446","unstructured":"Wykes T Reeder C Landau S Everitt B Knapp M Patel A Cognitive remediation therapy: predictive factors & side effects Unknown source 1994"},{"issue":"1","key":"10.1002\/14651858.CD000284.pub3-BIB0447|cit447","first-page":"16","article-title":"Preventive effect of ferrous sulfate on extrapyramidal side effects of neuroleptics","volume":"17","author":"Yan","year":"2004","journal-title":"Shandong Archives of Psychiatry [\u5c71\u4e1c\u7cbe\u795e\u533b\u5b66]"},{"issue":"6","key":"10.1002\/14651858.CD000284.pub3-BIB0448|cit448","first-page":"936","article-title":"The rehabilitation effect of group psychotherapy on chronic schizophrenic patient","volume":"21","author":"Yang","year":"2005","journal-title":"Occupation and Health [\u804c\u4e1a\u4e0e\u5065\u5eb7]"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0449|cit449","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0140-6736(77)91427-1","article-title":"Propranolol as an adjunct to the treatment of schizophrenia","volume":"2","author":"Yorkston","year":"1977","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD000284.pub3-BIB0450|cit450","first-page":"153","article-title":"A study on the relationship between the chlorprmazine plasma levels and clinical response to chlorpromazine administrations in the schizophrenics","volume":"27","author":"Yuan-Guang","year":"1994","journal-title":"Chinese Journal of Neurology and Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0451|cit451","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.1956.02960380027008","article-title":"Use of chlorpromazine and reserpine in the treatment of emotional disorders","volume":"160","author":"Zeller","year":"1956","journal-title":"Journal of the American Medical Association"},{"issue":"3","key":"10.1002\/14651858.CD000284.pub3-BIB0452|cit452","first-page":"185","article-title":"[only Chinese Title available]","volume":"5","author":"\u738b\u5f3a","year":"1995","journal-title":"Journal of Clinical Psychological Medicine [\u4e34\u5e8a\u7cbe\u795e\u533b\u5b66\u6742\u5fd7]"},{"issue":"6","key":"10.1002\/14651858.CD000284.pub3-BIB0453|cit453","first-page":"455","article-title":"[Title only available in Chinese characters]","volume":"21","author":"\u91d1\u5efa\u70fd","year":"2008","journal-title":"Shandong Archives of Psychiatry [\u5c71\u4e1c\u7cbe\u795e\u533b\u5b66]"},{"issue":"8","key":"10.1002\/14651858.CD000284.pub3-BIB0454|cit454","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1001\/archpsyc.55.8.754","article-title":"Randomised controlled trials in Archives of General Psychiatry (1959-1995): a prevalence study","volume":"55","author":"Ahmed","year":"1998","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0455|cit455","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0456|cit456","volume-title":"Tardive dyskinesia: a task force report of the American Psychiatric Association","author":"American Psychiatric Association","year":"1992"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0457|cit457","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1994"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0458|cit458","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/schbul\/19.3.609","article-title":"Subjective response to neuroleptics in schizophrenia","volume":"19","author":"Awad","year":"1993","journal-title":"Schizophrenia Bulletin"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0459|cit459","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1192\/bjp.170.1.2","article-title":"Early interventions in schizophrenia","volume":"170","author":"Birchwood","year":"1997","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0460|cit460","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bmj.315.7108.600","article-title":"Statistics notes. Trials randomised in clusters","volume":"315","author":"Bland","year":"1997","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD000284.pub3-BIB0461|cit461","first-page":"405","article-title":"The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use","volume":"54","author":"Boissel","year":"1999","journal-title":"Therapie"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0462|cit462","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1017\/S003329170002729X","article-title":"Antipsychotic drugs: is more worse? A meta-analysis of the published randomized control trials","volume":"24","author":"Bollini","year":"1994","journal-title":"Psychological Medicine"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0463|cit463","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1943-278X.1992.tb01040.x","article-title":"Schizophrenia - a high-risk factor for suicide: clues to risk reduction","volume":"22","author":"Caldwell","year":"1992","journal-title":"Suicide and Life-Threatening Behavior"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0464|cit464","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1440-1819.2004.01194.x","article-title":"Antipsychotic drug prescription for schizophrenia in East Asia: rationale for change","volume":"58","author":"Chong","year":"2004","journal-title":"Psychiatry and Clinical Neuroscience"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0465|cit465","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4613-4042-3_4","article-title":"Neuroleptics: clinical use in psychiatry","volume-title":"Handbook of Psychopharmacology","author":"Davis","year":"1978"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0466|cit466","unstructured":"Deeks J Issues in the selection for meta-analyses of binary data Abstracts of 8th International Cochrane Colloquium; 2000 Oct 25-28th; Cape Town, South Africa 2000"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0467|cit467","unstructured":"Delay J Deniker P CR Congres des Medicins alienistes et neurologistes de France. Luxembourg 1952 479"},{"issue":"6","key":"10.1002\/14651858.CD000284.pub3-BIB0468|cit468","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF02599201","article-title":"The unit of analysis error in studies about physicians' patient care behavior","volume":"7","author":"Divine","year":"1992","journal-title":"Journal of General Internal Medicine"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0469|cit469","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1002\/sim.1301","article-title":"Issues in the meta-analysis of cluster randomized trials","volume":"21","author":"Donner","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0470|cit470","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD000284.pub3-BIB0471|cit471","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"7","key":"10.1002\/14651858.CD000284.pub3-BIB0472|cit472","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jclinepi.2005.06.006","article-title":"Imputing missing standard deviations in meta-analyses can provide accurate results","volume":"59","author":"Furukawa","year":"2006","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0473|cit473","first-page":"97","article-title":"The third revolution in psychiatry: fluphenazine decanoate","volume-title":"The Future of Pharmacotherapy: Drug Delivery Systems","author":"Grozier","year":"1973"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0474|cit474","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/oxfordjournals.aje.a009904","article-title":"Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994","volume":"149","author":"Gulliford","year":"1999","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0475|cit475","volume-title":"Early Clinical Drug Evaluation (ECDEU) Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0476|cit476","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/BF02190336","article-title":"Transnational stability of gender differences in schizophrenia? An analysis based on the WHO study on determinants of outcome of severe mental disorders","volume":"242","author":"Hambrecht","year":"1992","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0477|cit477","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0478|cit478","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005] The Cochrane Library 2005"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0479|cit479","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org."},{"key":"10.1002\/14651858.CD000284.pub3-BIB0480|cit480","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3109\/00048679209072064","article-title":"Symptomatic response to antipsychotics differs between recent onset and recurrent chronic schizophrenic patients","volume":"26","author":"Hill","year":"1992","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0481|cit481","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0482|cit482","first-page":"357","article-title":"Content and methods of studies on the prevention and treatment of mental disorders in selected psychiatric journals","volume":"38","author":"Jenicek","year":"1990","journal-title":"Revue d'Epidemiologie et de Sante Publique"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0483|cit483","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1192\/bjp.165.6.787","article-title":"Post-mortem antipsychotic drug concentrations and unexplained deaths","volume":"165","author":"Jusic","year":"1994","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0484|cit484","first-page":"533","article-title":"High-dose versus low-dose strategies in the treatment of schizophrenia","volume":"21","author":"Kane","year":"1985","journal-title":"Psychopharmacological Bulletin"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0485|cit485","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0006-3223(90)90650-Q","article-title":"Enlargement of cerebral third ventricle in psychotic patients with delayed response to neuroleptics","volume":"27","author":"Kaplan","year":"1990","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0486|cit486","volume-title":"Positive and Negative Syndrome Scale (PANSS) Manual","author":"Kay","year":"1986"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0487|cit487","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1192\/bjp.167.2.184","article-title":"Gender and schizophrenia. Results of an epidemiologically-based family study","volume":"167","author":"Kendler","year":"1995","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0488|cit488","first-page":"1329","article-title":"no English title available","volume":"59","author":"Laborit","year":"1951","journal-title":"Presse Medicale"},{"issue":"2-3","key":"10.1002\/14651858.CD000284.pub3-BIB0489|cit489","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.schres.2005.04.008","article-title":"What does the PANSS mean?","volume":"79","author":"Leucht","year":"2005","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0490|cit490","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1192\/bjp.187.4.366","article-title":"Clinical implications of Brief Psychiatric Rating Scale Scores","volume":"187","author":"Leucht","year":"2005","journal-title":"British Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD000284.pub3-BIB0491|cit491","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/schbul\/sbl025","article-title":"Is the superior efficacy of new generation antipsychotics an artifact of LOCF?","volume":"33","author":"Leucht","year":"2007","journal-title":"Schizophrenia Bulletin"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0492|cit492","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/1097","article-title":"A behavior rating scale suitable for use in mental hospitals","volume":"7","author":"Lucero","year":"1951","journal-title":"Journal of Clinical Psychology"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0493|cit493","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1192\/bjp.176.3.249","article-title":"Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia","volume":"176","author":"Marshall","year":"2000","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0494|cit494","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1001\/jama.285.15.1987","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials","volume":"285","author":"Moher","year":"2001","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0495|cit495","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000468572","article-title":"Psychotropic drug prescription pattern in a developing country (Nigeria). The need for an essential psychotherapeutic drug list","volume":"17","author":"Odejide","year":"1982","journal-title":"International Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0496|cit496","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The Brief Psychiatric Rating Scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychological Reports"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0497|cit497","unstructured":"Prescription Pricing Authority: NHS 2003 http:\/\/www.ppa.org.uk\/index.htm"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0498|cit498","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1600-0447.1990.tb05312.x","article-title":"Antipsychotics in the elderly","volume":"358","author":"Rosen","year":"1990","journal-title":"Acta Psychiatrica Scandinavica Supplement"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0499|cit499","doi-asserted-by":"crossref","DOI":"10.1037\/11420-023","article-title":"Ratings of disturbance in various categories of behavior during hospitalization","volume-title":"The Gerain Quadruplets: a Study of Heredity and Environment in Schizophrenia","author":"Rosenthal","year":"1963"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0500|cit500","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0501|cit501","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/9780470712184.ch12","article-title":"Chapter 12: Interpreting results and drawing conclusions","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Sch\u00fcnemann","year":"2008"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0502|cit502","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(95)91508-7","article-title":"Chemical brain anatomy in schizophrenia","volume":"346","author":"Sedvall","year":"1995","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0503|cit503","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1176\/ajp.152.5.698","article-title":"Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients","volume":"152","author":"Szymanski","year":"1995","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0504|cit504","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1176\/ajp.153.4.519","article-title":"Course of treatment response in first-episode and chronic schizophrenia","volume":"153","author":"Szymanski","year":"1996","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0505|cit505","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1136\/bmj.317.7167.1181","article-title":"Content and quality of 2000 controlled trials in schizophrenia over 50 years","volume":"317","author":"Thornley","year":"1998","journal-title":"BMJ"},{"issue":"5","key":"10.1002\/14651858.CD000284.pub3-BIB0506|cit506","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta3050","article-title":"Methods for evaluating area-wide and organistation-based intervention in health and health care: a systematic review","volume":"3","author":"Ukoumunne","year":"1999","journal-title":"Health Technology Assessment"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0507|cit507","unstructured":"WHO: Global Health Statistics Online, 1998. WHO: Global Health Statistics Online, 1998. WWHO: Global Health Statistics Online, 1998 http:\/\/w3.whosea.org\/en\/section1174\/section1199\/section1567_6744.htm"},{"key":"10.1002\/14651858.CD000284.pub3-BIB0508|cit508","unstructured":"WHO: Essential Medicines 13th edition, WHO Model List 2003 http:\/\/www.who.int\/hac\/techguidance\/pht\/essentialmed\/en\/"},{"issue":"7","key":"10.1002\/14651858.CD000284.pub3-BIB0509|cit509","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1192\/pb.bp.108.021949","article-title":"Loss to outcomes stakeholder survey: the LOSS study","volume":"33","author":"Xia","year":"2009","journal-title":"Psychiatric Bulletin"},{"issue":"2","key":"10.1002\/14651858.CD000284.pub3-BIB0510|cit510","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000284.pub2","article-title":"Chlorpromazine versus placebo for schizophrenia","author":"Adams","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD000284.pub3-BIB0511|cit511","doi-asserted-by":"publisher","DOI":"10.1002\/14651858","article-title":"Chlorpromazine versus placebo for those with schizophrenia","author":"Thornley","year":"1998","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD000284.pub3-BIB0512|cit512","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000284","article-title":"Chlorpromazine versus placebo for schizophrenia","author":"B","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD000284.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T11:19:32Z","timestamp":1746098372000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD000284.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Schizophrenia Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,1,6]]},"references-count":512,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd000284.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,6]]}}}